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Clinical observation on mannitol intoxication. K. W. Lee, W.K. Lee,
S.B. Park, and H.C. Kim, Department of internal Medicine, Keimyung
University School of Medicine, Taegu, Korea. Mannitol is an osmotic
diuretic widely used in the diagnosis and prevention of acute oliguric
renal failure, acute cerebral edema and acute glaucoma. Mannitol,
largely excreted by the kidney, may accumulate in renal failure. The
syndrome of mannitol intoxication is clinically manifested as volume
overload, confusion, hyponatremia and an elevated osmolar gap. The
study included seven patients with serious mannitol intoxication who
came to our institution between 1985 and 1989. All seven patients had
received 579 214 g of mannitol to reduce the increased intracranial
pressure, and had a similar clinical picture consisting of CNS depres-
sion, stupor and pulmonary edema. There were 2 males and 5 females,
and with the mean age of 51.4 11.5 years. All patients had renal
failure, with a mean serum creatinine of 4.9 1.9 mg/dl. Five of 7
patients had massive proteinuria and four out of 7 had microscopic
hematuria. They had severe hyponatremia (mean sodium level, 118 7
mEq/liter) and a disproportionately high measured serum osmolality
(mean, 362 21 mOsm/liter). The mean calculated serum osmolality
was 289 30 mOsm/liter and mean osmolar gap was 73.9 23.3
mOsm/liter. There was a marked decrease in osmolar gap during
dialysis, from a mean of 87.6 mOsm/liter to 31.7 mOsm/liter during 6
hours of hemodialysis and from 31.7 mOsm/liter to 9.3 mOsm/liter 48
hours after the first dialysis treatment. Three out of 4 patients who were
treated with hemodialysis were improved, whereas none of three
patients not treated with hemodialysis showed any improvement.
Mannitol-induced metabolic alkalosis. C.H. Park, S.K. Park, and 5K.
Kang, Department of Internal Medicine, Chonbuk National University
Medical School, Chonju, Chonbuk, Korea. The infusion of hypertonic
mannitol increases the osmotic pressure of the extracellular compart-
ment and causes water to enter extracellularly from cells, resulting in
expension of the intravascular and extracellular volume. In victims of
cerebral vascular accident (CVA) associated with brain swelling, man-
nitol may be useful in transiently shrinking brain cells and lowering
intracranial pressure. In this study, 15% mannitol was administrated
intravenously to 21 CVA patients to evaluate their acid-base disorder.
Group A was infused with 15% mannitol 300 to 600 ml for 1 hour; Group
B, mannitol 1200 to 2600 ml for 4 hours; and Group C, mannitol 3200 to-
4900 ml for 6 hours each. The results were as follows.
Baseline
pH PCO2 HCO3 Na K Cl BUN Cr
Group A 7.43 39.8 25.3 140.9 4.3 106.0 17.9 1.03
N = 7 ±0.07 ±4.2 ±2.1 ±1.7 ±0.6 ±3.6 ±4.8 ±0.3
Group B 7.43 38.6 25.5 141.2 4.2 106.3 19.2 1.0
N = 9 ±0.02 ±2.6 ±1.8 ±2.8 ±0.3 ±3.5 ±3.0 ±0.1
Group C 7.41 34.6 24.9 143.6 4.2 109.0 22.5 1.3
N = 5 ±0.01 ±4.5 ±1.2 ±7.7 ±0.1 ±7.9 ±5.7 ±0.4
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After mannitol
pH PCO2 HCO3 Na K Cl BUN Cr
7.46a 4O.4 28.9a l39.6a 37 102.3a l6.Oa 0.7a
±0.04 ±5.0 ±2.9 ±4.0 ±0.8 ±4.0 ±7.8 ±0.3
747b 40.3' 29.la l38.3a 3W' l04.Oa l5.4a 0.7k'
±0.06 ±6.6 ±2.9 ±10.1 ±0.5 ±8.1 ±4.9 ±0.2
7.52a 33.8 277b 138.8 39b 104.3 21.5' 12b
±0.04 ±2.6 ±2.5 ±13.4 ±0.2 ±14.4 ±5.1 ±0.9
p < 0.01, b p < 0.05
Abbreviation is: CVA, cerebral vascular accident (ASDH: 7, ICH: 6,
SAl-I: 8)
Urine acidification in Korean hemorrhagic fever. G.H. Kim, Y.C.
Chung, CS. Lim, iS. Han, S. Kim, and J.S. Lee, Department of
Internal Medicine, Seoul National University College of Medicine,
Seoul, Korea. In Korean hemorrhagic fever (KHF), tubular dysfunc-
tions are expected according to the severe renal tubular damage. In
fact, impaired urine concentration is observed for a long time after
recovery of KHF and distal urine acidification defect was reported after
recovery of nephropathia epidemica. To evaluate the urine acidification
during the course of KHF and to evaluate the clinical usefulness of
urine anion gap as an index of urine ammonium excretion or acidifica-
tion defect, we serially measured the urine pH, PuCO2, urine ammo-
nium and urine anion gap in each phase of 10 patients with serologically
confirmed, typical type of KHF. Also, to compare the potential
acidification power, acid loading was made in convalescent phase
patients and normal controls. Urine pH had no differences among the
phases. PuCO2 was higher in the convalescent phase than in the oliguric
phase. Urine anion gap was higher in the oliguric phase than in the late
diuretic or convalescent phase. Daily urine ammonium excretion was
lower in the oliguric phase than in the late diuretic or convalescent
phase. Urine anion gap was inversely correlated with urine ammonium
excretion during the course of KHF (r, = —0.65, P < 0.05, Spearman).
In the oliguric phase, urine pH and anion gap were higher and urine
ammonium excretion was lower than those of normal controls, but in
the convalescent phase they were not different from those of normal
controls. Overt urine acidification defect was prominent in the oliguric
phase and declined thereafter. Acid loading tests performed during
convalescent phase were negative in all the patients. In conclusion,
urine acidification defect was observed during the course of KHF but
was recovered in the convalescent phase. Serial change of urine anion
gap was thought to reflect that of urine ammonium excretion.
Severe hypophosphatemia in hospitalized patients. S.J. Kang, KS.
Ha, B.H. Yoo, and S.S. Moon, National Medical Center, Department
of Internal Medicine. Hypophosphatemia is a relatively common find-
ings in hospitalized patients, especially severe hypophosphatemia has
been associated with significant morbidity. We reviewed severe hy-
pophosphaternia patients who admitted in National Medical Center
between January, 1989 and December, 1989. 1) The incidence of
hypophosphatemia was 9.6% (264 of 2762) and severe hypophos-
phatemia was 3.3%. 2) The predisposing factors were total parenteral
nutrition 50.5% (22 of 44), IV dextrose (15.9%), Antacid treatment
(15.9%) and diarrhea (15.9%). 3) Combined electrolyte abnormalities
were, hypocalcemia (54.5%), hyponatremia (3 1.8%) and hypokalemia
(27.2%). 4) More than 20 mg% of BUN was 45.5% and more than 1.4
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mg% of creatinine was 31.8% in 44 cases of severe hypophosphatemia.
5) Mortality incidence was 27.3% (12 of 44).
Clinical characteristics of the severe hypomagnesemia. J. T. Cho, Y.S.
Kim, J,H. Earm, J.5. Han, S. Kim, and J.S. Lee, Department of
Internal Medicine, Seoul National University College of Medicine,
Seoul, Korea. Severe hypomagnesernia has been associated with neu-
romuscular symptoms, hypocalcemia or hypokalemia, but little infor-
mation is available about the clinical characteristics of severe hypo-
magnesemia. To observe the frequency, etiology, neuromuscular
manifestations, laboratory findings, and treatment of severe hypo-
magnesemia, we reviewed the available records of all hospitalized
patients at the Seoul National University Hospital between January and
December, 1989 who had severe hypomagnesemia (serum magnesium
1.0 mEq/liter, measured repeatedly by atomic absorption spectropho-
tometry). The severe hypomagnesemia was 37 cases, which were 1.8%
of the total 2,074 measurements of serum magnesium. In the 30 cases of
severe hypomagnesemia reviewed, renal loss of magnesium was 17
cases, of which gentamicin, amphotericin B, and cisplatin nephrotox-
icity were 5, 5, and 2 cases respectively, diuretic phase of acute renal
failure, osmotic diuresis, and syndrome of inappropriate antidiuretic
hormone secretion were 3, 1, and I cases, respectively, decreased
intake and extrarenal loss of magnesium was 13 cases, of which
decreased intake was 11 cases and continuous arteriovenous hemofil-
tration was 2 cases, The neuromuscular manifestations were muscle
weakness (25/26), paresthesia (7/26), muscle tremor (6/26), and carpo-
pedal spasm (3/26). The serum calcium and potasium status at minimal
serum magnesium level were hypocalcemia and hypokalemia (17/29),
hypocalcemia and normokalemia (7/29), and normocalcemia and
normokalemia (5/29). The serum magnesium level (mean SD; 0.9
0.1 mEq/liter) was well correlated with the serum calcium level (mean
SD; 7.9 1.0 mg/liter) (r = 0.62, P < 0.01), but not with the serum
potassium level (mean SD; 3.5 0.7 mEq/liter) (r 0.27, P> 0.05).
The treatment was removal of etiologic factors and supplement of
deficient elements, and the mean duration of recovery was 15 days (3
days—2 months) in the renal loss of magnesium, 9 days (5—15 days) in the
decreased intake and extrarenal loss of magnesium,
Hypokalemic effects of nebulized salbutamol in chronic renal failure.
M,J. Kim, KS. Chung, C. Y. Kim, Y,B. Kim, and T.B. Park, Depart-
ment of Internal Medicine, Inha University College of Medicine,
Beta-agonist drugs are known to cause hypokalemia in the treatment of
asthma and premature labor. They induce an acute intracellular shift of
potassium, therefore, they may be useful in acute management of
hyperkalemia. We studied the potassium-lowering effects of nebulized
salbutamol (a beta-2 agonist) in hemodialysis patients with hyperkale-
mia (K > 6.0 mEq/liter). Following informed consents a total of 12
patients were studied in the fasting state 72 hours after the previous
dialysis session. Two groups of patients received either salbutamol (20
mg) or saline (placebo) inhaled by nebulizer over 10 minutes, Blood
samples were obtained at baseline (K = 6.4 + 0.4 mEq/liter), and
every 30 minutes for 3 hours and vital signs were monitored. Salbuta-
mol therapy resulted in a significant fall in the plasma concentration of
potassium at 30 minutes (5.8 0.6 mEq/liter), peak reductions at 90
minutes (5.2 0.5 mEq/liter) compared to placebo treatment (6.3 0.2
to 6.0 0.2 mEq/liter). Salbutamol did not produce significant changes
in blood pressure or heart rate without any serious side effects. We
suggest that beta-2 adrenergic stimulation by nebulized salbutamol is a
safe and effective alternative for acute treatment of hyperkalemia in
chronic renal failure.
Clinical significance of serum potassium in chronic hemodialysis pa-
tients. C.H. Kim, S.S. Kim, E.T. Kang, and S.H. Yu, Department of
Internal Medicine, Chung Ang University Hospital. Chronic hernodial-
ysis patients have been experienced hypotension, hypertension, elec-
trolyte disturbances and hemorrhagic events frequently. Among elec-
trolyte disturbances, hyperkalemia is usually complicated with
inadequate dialysis therapy or dietary indiscretion and less frequently
with single needle dialysis, hemolysis or severe hyperglycemia in
diabetic patients. Therefore to evaluate the clinical significance of
hyperkalemia and seasonal trend of serum potassium level during the
maintenance hemodialysis we studied the 116 (76 male and 40 female)
chronic hemodialysis patients since 1986 retrospectively. The results
were as follows: 1.) Mean age was 40.2 years (male 36.9 years, female
45.2 years). 2.) Mean duration of hemodialysis was 18.1 months (range
from 6 months to 43 months). 3.) Mean serum potassium levels had
bimodal pattern throughout the year. In January and July, mean
potassium level was higher (5.93 mEq/liter and 6.09 mEq/liter, respec-
tively) and lowest in April (5.53 mEq/Iiter). 4.) There was no significant
statistical difference in mean potassium level between that of survived
patients and of dead patients (5.72 0.66 mEq/liter vs. 5.72 0.61
mEq/liter, P> 0.05). 5.) There was no significant statistical difference
in peak potassium level between that of survived patients and of dead
patients (7.17 1.01 mEq/liter vs. 7.24 1.10 mEq/liter, P> 0.05). 6.)
15 patients had been suffered 18 episodes of symptomatic hyperkale-
mia. Among them, the individual risk of severe symptomatic hyperkale-
mia was 0.37/year which was higher 12 times than that of whole patients
(0.03/year). 7.) The mean potassium level requiring treatment for
clinical symptoms was 8.25 mEq/liter.
Glomerular and tubular function in healthy Korean kidney donors.
D.C. Han, S.K. Lee, MS. Park, S.D. Hwang, and NB. Lee, Hyonam
Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea. The
remaining kidney after unilateral nephrectomy undergoes functional as
well as morphological changes. We measured glomerular and tubular
function before and after donor nephrectomy to evaluate functional
changes after uniateral nephrectomy over time, Preoperative baseline
studies obtained from 49 kidney donors form the basis of this report.
GFR were obtained by creatinine clearance (Car) and by SSmTcDTpA
(DTPA-GFR). Urine concentrating, diluting and acidifying capacity
were tested by standard methods. Mean Cr (N = 30) was 94.1
ml/min/l.73 m2 and DTPA-GFR (N = 30) 106.5 ml/min/1.73 m2.
Maximal urine osmolality (Uosm N = 25) was 966.4 95.1 mOsm/kg
after fasting for 17 hours and loss of 3.5% of body weight. Uosm after
5 unit of vasopressin was 847.7 135.0 mOsm/kg. Minimal Uosm (N =
47) was 95.0 35.3 mOsm/kg in 2 hours after i.v. infusion of 20 mI/kg
of 5% dextrose solution. Fraction of water load excreted after 4 hours
was 87 30%, Maximal urine flow was 8,1 2.0 mI/mm and maximal
clearance of free water was 5.7 1.7 mI/mm. Urine pH decreased from
6.7 0.9 to 5.3 0.4 in 6 hours after NH4CI loading while serum
bicarbonate decreased from 27.7 2.7 to 23.9 2.9 mEq/liter.
Hyperkalemia following renal transplantation. H.C. Kim, K. W. Lee,
W.K. Lee, and SB. Park, Department of Internal Medicine, Keimyung
University School of Medicine, Taegu, Korea. Disorders of renal
tubular function following renal transplantation are being recognized
with increasing frequency. The incidence of hyperkalemia following
renal transplantation is significantly increased in cydosporine treated
patients compared to those, treated with azathioprine. The inpatient
and outpatient records of consecutive patients undergoing renal trans-
plantation at Keimyung University Medical Center from Dec. 1984, to
Dec. 1989, were reviewed for the development of hyperkalemia during
the 3 month period immediately following renal transplantation. Unex-
plained hyperkalemia developed in 33 of: 115 (28.7%) cyclosporine
treated renal transplant recipients. The mean age was 34.2 years (range:
18—52) and male to female ratio was 26:7. The average onset of
hyperkalemia was 15.4 days (range: 8—35) and the mean duration of
hyperkalemia was 17.5 days. Hyperkalemia was mild to moderate in
most case (K:5.l—6.4 mEq/liter), but only 3 cases were severe (K  6.5
mEq/liter) enough to require emergency treatment. The mean dosage of
cyclosporine was 9.0 1.8 mEq/liter, and cyclosporine blood levels
were in the higher range (594 268 ng/ml). There was no correlation
between the onset of hyperkalemia and rejection. Hyperkalemia re-
solved spontaneously in 19 cases (57.6%) and was responsive to the
administration of thiazides and K-exchange resin in 14 cases (42,4%).
The elucidation of the exact mechanism of cyclosporine associated
hyperkalemia following renal transplantation will require further study.
Role of ANP (atrial natriuretic peptide) in the adaptation of sodium
excretion following unilateral nephrectomy. Y.K. Kim, S. W. Lee, K.H.
Choi, H. Y. Lee, and D.S. Han, Department of Internal Medicine,
Yonsei University, College of Medicine, Seoul, Korea. Our study was
designed to evaluate the role of ANP for the adaptive changes in renal
Na excretion in 5 kidney transplantation donors before and after
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unilateral nephrectomy. Objectives were studied after midnight fasting.
One liter of tap water was ingested and 0.9% saline was infused at the
amount of 1.8 of body weight. Measurements include ANP, PRA
(plasma refine activity), BUN, creatinine, electrolyte and osmolarity of
serum, hematocrit and BUN, creatinine, electrolyte and osmolarity of
urine. The above-listed measurements were performed before volume
expansion and every 30 minutes thereafter for 4½ hours. Plasma ANP
and PRA were determined by radioimmunoassay. The results were as
follows. 1) Mean age of patients was 43.4 12.3 (mean sn) years and
mean follow-up duration was 17 0.7days. 2) Glomerular filtration rate
was significantly increased 30 minutes after volume expansion in both
pre- and post-nephrectomy. There was no significant difference be-
tween pre- and post-nephrectomy. 3) Excretion of urinary sodium and
urine volume was significantly increased 30 minutes after volume
expansion in both pre- and post-nephrectomy patients. There was no
significant difference between pre- and post-nephrectomy. 4) FENa
(Fractional excretion of Na) and free water clearance were significantly
increased 1 hour after volume expansion in both pre- and post-
nephrectomy. These values of post-nephrectomy were significantly
higher than those of pre-nephrectomy. 5) The levels of ANP showed
tendency of increase after nephrectomy but were not statistically
different between pre- and post-nephrectomy. 6) The levels of PRA
showed tendency of decrease but were not statistically different in both
pre- and post-nephrectomy. 7) Blood pressure, pulse rate and hernato-
crit were not statistically different in both pre- and post-nephrectomy.
Though we cannot prove statistically whether the increase in FENa after
unilateral nephrectomy is due to an increase of ANP following reduced
renal mass, there was some tendency of increase of plasma ANP.
Futher studies for clarifying the factors which influence the adaptation
mechanism of reduced renal mass in humans are needed.
Bone mineral density of normal Korean children. B. Y. Lim, B.-S. Cho,
Y.S. Kim, K.W. Kim, and Y.K. Choi, Department of Pediatrics,
Department of internal Medicine, College of Medicine, Kyung Hee
University, Seoul, Korea. The diagnosis of renal osteodystrophy and
osteoporosis is established by clinical manifestations, biochemical
laboratory tests, x-ray and bone scan but early diagnosis, determination
of treatment of various metabolic bone diseases are not satisfied with
any of those methods. The photon absorptiometry, first introduced by
Cameron, is generally considered the best available quantitative bone
mineral content (BMC) or bone mineral density (BMD, BMC/area,
glcm2) and detecting changes of BMD in the early stage of various
metabolic bone diseases. The main problems with this technique are the
large dosage of radiation exposure, long measurement time, and low
accuracy but dual energy x-ray absorptiometry is the small dosage of
radiation exposure, short measure time, and more high accuracy. Dual
energy x-ray absorptiometry has been shown to be a reliable, repro-
ducible, and noninvasive way to assess bone mineral status. We
evaluated the bone mineral density of normal Korean children for
normal and standard values. We determined the bone mineral density of
whole body in 181 children 0 to 15 years of age using dual x-ray
absorptiometry from March 1989 to February 1990. No children had
known bone disorders, other chronic disorders or history of drug
medication. All children were between the third and 97th percentiles on
the Korea growth curves. Results: 1.) Increasing BMD was demon-
strated in these children, with female children having lower values than
male children. 2.) BMD at the skull bone was increased relatively
regular 0 to 10 years of age but 11 years and above patients had variable
changes. 3.) BMD of the pelvis and spine had a similar pattern to the
skull. 4.) BMD of pelvis was the most highly correlated (male r = 0.935,
female r = 0.962) and had the least interference between neighboring
tissues. Conclusion: We determined bone mineral density of whole
body in 181 children 0 to 15 years of age using dual x-ray absorptiom-
etry, which is the small dosage of radiation exposure, short measure
time, and greater accuracy.
Serum phosphorous lowering effects of sucralfate in patients with
chronic renal failure. M.J. Kim, C.G. ihm, T.W. Lee, and K.Y. Kim,
Department of internal Medicine, Kyung Hee University Medical
Center, Seoul, Korea. Renal osteodystrophy associated with a second-
ary hyperparathyroidjsm is induced by hypocalcemia in chronic renal
failure. The low serum calcium levels are caused in part by hyperphos-
phatemia. Aluminum hydroxide is used to correct hyperphosphatemia
by binding phosphate in the bowel and reducing the absorption of
phosphate. However, aluminum intoxication can induce anemia, osteo-
malacia, and dementia. For these reasons, it is desirable to reduce the
exposure to aluminum. We evaluated the effect of sucralfate (aluminum
salt of sucrose octasulfate) on the level of serum phosphorous, calcium,
aluminum and parathyroid hormone (C-terminal) at 1 week intervals
during 3 weeks of administration. The result were as follows: Serum
phosphorous level was significantly decreased from 7.86 1.49 mgldl
before sucralfate administration to 4.24 0.19 mg/dl at 3 weeks after
administration (P < 0.01). Serum calcium level was significantly in-
creased from 6.68 0.74mg/dl before sucralfate administration to 8.50
0.71 mg/dl at 3 weeks after administration (P < 0.01). Serum
aluminum level was significantly increased from 23.13 10.40 mg/dl
before sucralfate administration to 105.83 30.71 mg/dl at 3 weeks
administration (P < 0.01). Serum PTH level was decreased from 595.65
351.28 pg/ml before sucralfate administration to 485.82 296.40
pg/mI at 3 weeks after administration (no statistical significance P >
0.1). In conclusion, sucralfate can be used for the reduction of the
concentration of serum phosphorous and to increase the level of serum
aluminum in patients with chronic renal failure.
Effect of Rocaltrol (1,25-(OH)2-cholecalciferol) in dialysis patients.
S. W. Lee, J.H. Choi, K.H. Choi, H. Y. Lee, and D.S. Han, Department
of internal Medicine, Yonsei University College of Medicine, Seoul,
Korea. To investigate the efficacy of Rocaltrol, the most active known
form of vitamin D, in the treatment of renal osteodystrophy, Rocaltrol
was tried in 30 maintenance dialysis patients (HD:23, CAPD:7) for 12
weeks, and several biochemical and bone parameters including para-
thyroid hormone (PTH), metacarpal index (MCI) and bone mineral
density (BMD) of lumbar spine were evaluated regularly during ther-
apy. Calcium supplements were not given. Dosages of Rocaltrol and
aluminium hydorxide preparations were increased as necessary to keep
the plasma calcium concentration above 9 mg/dl and the phosphate
below 6 mg/dl. The plasma calcium concentration measured every 2
weeks, started to rise during the first 2 weeks, and was significantly
higher at 12th week than the pretreatment value (mean SE, mg/dl, 8.64
0.61 vs. 9.92 1.1; P <0.05). PTH concentration which was 6.19
2.91 ng/ml before treatment, showed significant fall at 4th week of
therapy and maintained below pretreatment values for the remaining
follow-up period (4.64 2.87, P < 0.05). BMD utilizing dual photon
absorptiometry and MCI were increased 12 weeks after treatment from
1.04 0.11 g/cm2 and 0.49 0.10, to 1.07 0.12 (P <0.05) and 0.52
0.09. Any remarkable changes in hematologic findings or blood
chemistry including blood sugar, uric acid, SGOT and SGPT were not
noted during period. Before the trial 3 patients complained of bone
pains, which disappeared during trial. There were 3 patients of mild
pruritus and one case of impotence with short duration. From the above
results, it seems that Rocaltrol can be considered as effective agent for
improving renal osteodystrophy without significant side effects, but
further studies for the evaluation of the histologic changes and long
term side effects will be needed.
The change of bone mineral density (BMD) and total body calcium
(TBC) after renal transplantation (KTP). J.H. Jeon, T. W. Lee, C.G.
ihm, and M.J. Kim, Department of internal Medicine, Kyung Hee
University School of Medicine, Seoul, Korea. Following successful
KTP, the progression of renal osteodystrophy is not well defined and
reported to be diminished, stopped or improved after KTP. BMD and
TBC may be increased with the improvement of renal function,
hyperthyroidism and the renal excretion of aluminum. As steroid may
induce osteoporosis, the changes of BMD and TBC after KTP will be
difficult to predict. To evaluate the change of BMD and TBC after KTP,
we measured BMD and TBC using dual X-ray energy absorptiometry
before and 1 month after KTP in 10 patients with chronic renal failure.
The results were as follows: after I month of KTP, the serum level of
phosphorus and PTH was significantly decreased compared with pre-
transplantation values. Serum alkaline phosphate was also decreased
but not significant statistically (phosphorus: 6.13 1.41 mg/dI vs. 3.65
0.98 mg/dl, P < 0.005; PTH: 672.42 239.9 pg/mI vs. 114.44 83.2
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pg/mi, P < 0.005;alkaline phosphate: 64.5 32.76 lU/liter vs. 42 14.4
LU/liter, P < 0.1). The changes of bone density were as follows.
Bone mineral density g/cm2
Pre-KTP Post-KTP
Head 2.0916 0.2980 2.0868 0.2646
Arm 0.8014 0.0845 0.8040 0.0832
Leg
Trunk
1.1053 0.1324
0.8723 0.0895
1.1013 0.1275
0.8854 0.0875
Rib 0.6860 0.0655 0.7031 0.0714
Pelvis 0.9954 0.1237 1.0041 0.1174
Spine 1.0560 0.1270 1.0678 0.1322
Thoracic 0.9976 0.1266 1.0359 1.1150
Lumbar 1.0972 0. 1756 1.1314 0.1631
Total 1.0609 0.1011 1.0623 0.0949
The serum calcium and total body calcium were increased but not
significant statistically. (calcium: 8.21 1.11 rng/dl vs. 8.86 0.50
mg/di, F> 0.1; TBC: 934.2 143.0 g vs. 938.0 139.8 g, P >0.1). In
conclusion, the serum calcium, TBC and BMD were not increased
significantly. Long-term follow-up will be need to evaluate the changes
of BMD and TBC after KTP.
Alteration of sodium-dependent transport systems in renal plasma
membranes of cadmium-intoxicated animals. H. 1'. Lee, K,R. Kim, and
Y.S. Park, Department of Physiology, Kosin Medical College, Pusan,
Korea. In a previous study (Kidney mt 37:727—735, 1990) we have
demonstrated that renal cortical brush-border membrane vesicles
(BBMV) isolated from Cd-intoxicated rats showed a greatly diminished
capacity for Na-driven glucose transport. In the present study we
extend our observations to transport systems for amino acids and Krebs
cycle intermediates. In the renal cortical BBMV of Cd-intoxicated rats,
Na-dependent uptake of various amino acids (alanine, proline, lysine
and glutamic acid) are markedly attenuated. Experiments involving
BBMVs isolated from Cd-intoxicated rabbits indicated that the inhibi-
tion of Na-dependent amino acid and glucose cotransports occurred
both in early and late segments of the proximal renal tubule. In
basolateral membrane vesicles (BLMV) of either Cd-intoxicated rats or
rabbits, Na-dependent uptakes of succinate and citrate were greatly
suppressed. These results indicate that cadmium intoxication impairs
various Na-dependent secondary active transport systems in brush-
border and basolateral membranes of proximal renal tubules.
Hypotensive effect and mechanism of furosemide. K.C. Choi, Y.H.
Park, K.S. Kim, Y.J. Kang, and P.S. Hee, Department of Medicine
and Department of Physiology, Chonnam University Medical School,
Kwangju, Korea. Furosemide has widely been used for the treatment of
various disease entities including renal diseases, cardiac diseases,
pulmonary edema and hypertension. Among them, its antihypertensive
mechanism has not been clarified yet. We examined the effect of
furosemide on blood pressure and renal excretion to learn its action
mechanism. Effects of furosemide on the isolated thoracic aortic rings
were also examined. Infusion of furosemide (2 mg/kg/mm, 45 mm) in
pentobarbital-anesthetized rats rapidly increased urinary volume and
excretion of sodium. The blood pressure was not affected during the
infusion, but was significantly decreased during the recovery periods
after terminating the infusion, On the contrary, blood pressure was
affected neither during nor after terminating the furosemide infusion in
the bilaterally nephrectomized rats. Injection of furosernide (20 mg/kg)
as a single bolus caused only a transient decrease of blood pressure
regardless of whether kidneys were intact or removed. Furosemide
relaxed aortic rings precontracted with phenylephrine (10—s M) in a
dose-dependent manner. These results suggest that the rapid and
transient depression is related with vasodilation and the delayed pro-
longed depression with a volume contraction caused by renal excretion.
Captopril-stimulated renography vs. renal vein renins (RVR's) in
two-kidney, two-clip (2K, 2C) hypertension. C.H. Park, G.M. Kang, and
H. C. Park, Department of Internal Medicine, Hanyang University
Hospital, Korea. Debate exists over the renin-dependency of individual
kidney function and the concomitant hypertension in bilateral renal
artery stenosis (bRAS). Prior studies suggest captopril (C) lowers mean
arterial pressure (MAP), reduces kidney function and alters the reno-
gram of the stenotic kidney in a 2K, 1C model. We examined MAP,
CIN, CPAH, RVR's and renography with TcmDTPA and I-''-
hippuran of each kidney in a canine model of 2K, 2C hypertension (N
= 10) before and after captopril (1.5 mg/kg bolus and 1.5 mg/mm
infusion). Two days after the creation of bRAS (40—60% and 50-80%
reduction), the elevation of MAP was significantly lowered (145.4 5.3
vs. 115.8 7.5 mm Hg, P < 0.001) after captopril. Captopril also
reduced total GFR (P < 0.005) with reductions in both the more stenotic
(MS) kidney (14.6 3.6 vs. 6.7 2.0 mI/mm, P < 0.01) and less
stenotic (LS) (29.1 3.7 vs. 20.7 4.6 ml/min, P < 0.007). Baseline
and stimulated RVR's correlated inversely with ipsilateral CIN, CPAH,
hippuran uptake and cross sectional area of the arterial lumen. Capto-
pril enhanced the RVR ratio (MS/LS) from 3.4 to 4.7 and the diagnOstic
sensitivity for both the Tc-DTPA and j)31 hippuran renograms in all
dogs studied. The changes in Tc-DTPA uptake of each kidney after
captopril correlated with the reductions in CIN (P < 0.005). Captopril
renography may be a suitable noninvasive tool to complement, or
supplant, invasive RVR's as an index of renal perfusion and function in
2K, 2C hypertension.
Effect of cyclosporine administration to PAN induced nephrosis In rats.
C. Ko, and J. Koo, Department of Pediatrics, School of Medicine,
Kyungpook National University, Taegu, Korea. This experimental
study was conducted to determine the effect of T cell immunity, as
judged by changes observed by cyclosporine administration, to PAN
induced nephrosis in rats. Sprague-Dawley rats weighing 150—200 g
were used and divided into controls, Group I (PAN intraperitoneally)
and Group II (PAN intraperitoneally, followed by cyclosporine subcu-
taneously for 2 weeks). Twenty-four-hour urinary protein excretion was
measured on days 0, 7, 14 and 21. On 21°' day, rats were sacrificed for
determination of total serum protein, albumin and cholesterol levels.
And anionic sites of lamina rara externa was determined by using PEL
as cationic probes. The following results were obtained. Twenty-four-
hour urinary protein excretion (mg/day) was significantly increased to
185.2 94.9 on 7th day compared to 2.88 1.20 on day 0 (P <0.01),
and decreased gradually to 40.9 33.7 on 21thday. No differences were
noted between Groups I and II. Total serum protein and albumin did not
show significant difference in Groups I and II compared with controls,
however, serum cholesterol levels were higher than controls. The
number of anionic sites per I m length of glomerular basement
membrane in Groups I and II were 10.4 1.4 and 10.2 1.7,
respectively. And these values were significantly lower than control
value, 14.6 1.2. However, there was no difference between Groups I
and II. In light microscopical observation, interstitial infiltration
of mononuclear cells was noted in Groups I and LI, with more
prominant degree in Group II. In summary, present study, except for
inducing mononuclear cell infiltration in renal interstitium, did not
demonstrateany significant changes in renal epithelial cells, suggesting
that T cell immunity had no significant effect on PAN-induced nephrosis
in rats.
Astudy on the allergy in childhood nephrotic syndrome. D.K. Jin, H.I.
Cheong, J.G. Kim, Y. Choi, K.W. Ko, M.K. Kim, and Y.Y. Kim,
Department of Pediatrics and Internal Medicine, College of Medicine,
Seoul National University, Seoul, Korea. To investigate the role of type
I hypersensitivity on the pathogenesis of idiopathic nephrotic syn-
drome, we evaluated the incidence of allergy history and allergen skin
test, allergic specific IgE (RAST), basophil histamine releasability tests
were performed in nephrotic syndrome patients. The study included 28
idiopathic MEMS 12, FSGS 8, steroid responsive NS 8 and S secondary
(HBV associated MN 4, FSGN 2, SLE 2) nephrotic patients. The
results were as follows.
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P
Idiopathic NS Secondary NS value
Incidence of allergy 8/28 (29%) 1/8 (13%) 0.44
history
Positive results of 4/28 (14%) 0/8 (0%) 0.35
skin test
Positive results of 3/28 (11%) 0/8 (0%) 0.46
RAST
Positive results of 3/28 (11%) 0/8 (0%) 0.46
BHR
Mean serum total IgE 704 l342' lU/mI 110 56.6 lU/mi 0.03
Mean total eosinophil 233 384/mm3 96 127/mm3 0.12
count
a basophil histamine releasability test
b mean standard deviation
In conclusion, the observed significantly higher level of IgE in idio-
pathic nephrotic syndrome patients could not be explained by the
significant role of type I hypersensitivity on the pathogenesis of
idiopathic nephrotic syndrome.
Liver disease in Korean HBsAg carriers with renal disease. J.H.
Chung, Y.K. Kim, K.H. Choi, S.K. Ha, H. Y. Lee, and D.S. Han,
Department of Internal Medicine, Yonsei University College of Medi-
cine, Seoul, Korea. To assess the frequency of significant liver diseases
in HBsAg-positive renal diseases patients, 19 end-stage renal disease
(ESRD) and 12 glomerular disease patients with normal or minimally
elevated transaminase levels underwent peritoneoscopic liver biopsy,
and biochemical liver tests and histologic changes were analyzed
according to the positivity of HBeAg. The results of liver biopsy were
chronic active hepatitis (CAH) and/or cirrhosis in 18 cases (cirrhosis 5,
CAH with cirrhosis 2, CAH 11), chronic persistent hepatitis (CPH) or
nonspecific reactive hepatitis (NRH) in 10 cases, and normal histology
in 3 cases. HBeAg was positive in 22 carriers and the remaining 9
patients were anti-HBe positive. All patients carrying HBeAg revealed
features of CAH and/or cirrhosis except 6 cases who had NRH or CPH.
On the other hand, only two patients were found to have cirrhosis
among anti-HBe positive patients. Forty-one percent of patients with
normal liver function test had characteristics consistent with CAH or
cirrhosis. From the above results, it can be concluded that the levels of
transaminase does not closely correlate with the seventy of histologic
changes, whereas the positivity of HBeAg seems to be the reliable
index for pathologic information on hepatic status in HBsAg-positive
renal disease patients.
Effect of serum urokinase on urine fibrinolytic activity. S. Y. Hong,
K.S. Kim, and H.B. Lee, Department of Internal Medicine, Soonchun-
hyang University Hospital, Korea. To assess the effect of plasma
urokinase level on urine fibrinolytic activity, fibrinolytic activity of
dextran sulfate euglobulin fraction was measured on the plasminogen-
rich fibrin plate before, during, and after the urokinase infusion in 5
cases of cerebral thrombosis. The fibrinolytic activity of euglobulin
increased during urokinase infusion by dose dependent pattern (mean:
230 BAU; range: 173—333 BAU, N = 4) and decreased below the basal
level after cessation of urokinase (mean: 18 BAU, range: 0—27 BAU, N
= 4). There was a reverse correlation between the urine fibrinolytic
activity and serum fibrinolytic activity in all cases (r = —0.75, 0.01 <P
<0.02 in case 2; r =
—0.88, 0.0001 <P < 0.0005 in case 3; r = —0.74,
0.05 <P < 0.10 in case 1-a; and r =
—0.59, 0.05 <P < 0.10 in case 1-b).
This finding suggests that the urine fibnnolytic activity production is
under the control of the serum urokinase level with a feedback
mechanism, and that the kidney might be the essential organ providing
the systemic intrinsic fibrinolytic activity.
Dissolution theraphy of uric acid calculi. M.H. Cho, K.B. Kim, and
H. Y. Rhew, Department of Urology, Kosin Medical College, Pusan,
Korea. Uric acid is well known to dissociate in relation to pH. Before
the advent of endourology, uric acid calculi were managed by a variety
of conservative and/or surgical approaches. The former method in-
cludes the administration of a high fluid intake, allopurinol therapy and
either oral urinary or intravenous alkalinization with agents, such as
0.167 molar lactate. With development of endourology more aggressive
approaches to dissolution theraphy is done, which includes direct
irrigation through a percutaneous nephrostomy tube or a ureteral
catheter. We describe our experience with 6 patients with uric acid
stones who were in a uremic state. The following results were obtained.
1.) Most patients had oliguria, acute onset flank pain. 2.) Three patients
had nephrectomy with renal stone or renal Tbc, I with contralateral
renal agenesis, 1 with cataract, 1 with SLE. 3.) All patients except SLE
had acute renal failure, and they recovered within 3 weeks after
therapy. 4.) Most patients had hyperuricemia with hyperuricosuria and
low pH, which was controlled with oral allopurinol and NaHCO1
irrigation. 5.) Three patients had percutaneous nephrostomy, and 3
patients ureteral catheterization with renal pelvis irrigation. All stones
were successfully dissolved within 3 weeks.
Incidentally detected renal cell carcinoma: A report of 9 cases. K. T.
Sung and J.B. Yoon, Department of Urology, College of Medicine,
Pusan National University, Pusan, Korea. With wide clinical applica-
tions of abdominal ultrasonography and computerized tomography (CT)
in recent years, the proportion of incidentally diagnosed renal cell
carcinoma has been steadily increasing. We have experienced 9 cases of
incidental renal cell carcinoma which have been discovered during the
evaluation of the diseases in urologic or non-urologic fields of medicine.
The diagnostic modalities used were ultrasonography in 5 and CT in 2
for the evaluation of gastrointestinal symptoms in internal medicine, CT
in 1 for the evaluation of biliary tract disorder in general surgery and
IVP in 1 for the evaluation of bladder cancer. The sizes of tumors were
less than 3.0cm in 2, between 3.1 cm and 6.0cm in 3 and between 6.1
cm and 9.0 cm in 4. The distribution of stages according to Robson
classification were stage I in 5, stage II in 3 and stage Ilib in I. The
distribution of grade were grade I in 4, grade II in 3, grade III and IV in
1 each. With wide clinical applications and the routine health check-up
using abdominal ultrasonography or CT, the prognosis of renal cell
carcinoma will be improved by the early detection followed by early
surgical treatment.
Low signal intensity in the outer medulla of kidney on magnetic
resonance image (MRI) in Korean hemorrhagic fever (KHF). Y.G. Kim,
S.H. Kim, J.S. Han, S. Kim, and J.S. Lee, Seoul National University
College of Medicine, Seoul, Korea. Although many imaging techniques
were reported in KHF, no one specifically demonstrated the main renal
pathologic findings of hemorrhage in the renal medulla, especially in the
outer medulla. To visualize renal medullary hemorrhage in KHF, we
observed 25 (one to four serial MRI on each patient from 6 to 99 days
of illness) transaxial MRI of kidney in 14 patients with positive serologic
confirmation because of its sensitivity in detecting hemorrhage. Both Tl
and T2 weighted imaging (500/30, 2000/80 msec; TRiTE) by 2.0-Tesla
system (Spectro-20000, Goldstar) were performed in each examination
except four in which only T2-weighted imaging was done. Renal cortex
and medulla was clearly differentiated in all the twenty-five T2 weighted
images; the striking abnormalities were the band like low signal
intensity zone at outer medulla allowing differentiation from inner
medulla in 20 examinations. The remaining five showed low signal
intensity in the entire medulla. On Ti weighted images, corticomedul-
lary differentiation was seen in all 21 examinations, and low signal
intensity was confined to outer three to four millimeters of the medulla
in seven. We proposed that low signal intensity along the medulla
(especially outer medulla) is fairly constant and characteristic MR
findings in KHF and possibly represent medullary hemorrhage and
subsequent pathologic changes.
A review of urinary tract pathogens and antibiotic susceptibility for the
past 3 years. R. Chun, D.W. Chae, Y.C. Lee, and H. Y. Oh, Department
of internal Medicine, Hallym University College of Medicine, Korea.
In inpatients or outpatients with urinary tract infections (UTI5), specific
therapy should be preceded by careful urine examination and bacteri-
ologic study. A clinical study on patients with UTIs was done for
observation of causative organisms, their antibiotic susceptibility, and
guide of therapy at Hangang Sacred Heart Hospital for the years 1987,
1988 and 1989. The following results were obtained: 1)1278 patients
were observed, in whom community-acquired UTIs were 731 cases,
hospital acquired UTIs were 547 cases. 2) The ratio of male to female
was 1:3.9 with community-acquired UTIs and 1:0.7 with hospital
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acquired UTIs. 3) In age distribution, the majority of female patients
with community-acquired UTIs were seen in 20 to 49 years (52.8%). 4)
The precipitating factors of hospital-acquired UTIs were indwelling
catheter (92%), cystostomy, cystoscopy, retrograde pyelogram, inter-
mittent nelatonization, respectively. The underlying diseases of hospi-
tal-acquired UTIs were cerebrovascular accident (42%), burn (18%),
diabetes mellitus (14%), traumatic urethra injury (6%), respectively. 5)
The most common pathogens of hospital-acquired UTIs were Pseudo-
rnonas aeruginosa (24.2%), E. coil (14.6%), coagulage(—) staphylococ-
cus (13.6%), Klebsiella (10%), Enterobacter (9.7%), Enterococcus
(8.8%), respectively. The most common pathogens of community-
acquired UTIs were E. coli (44.9%), coagulase(—) staphylococcus
(24.8%), respectively. But coagulase(—) staphylococcus were markedly
increased than previous report. 6) The susceptibility rates of commu-
nity-acquired E. co/i was 55% to kanamycin, 98% to amikacin, 84% to
tobramycin, 85% to gentamicin, 68% to cephalothin. The susceptibility
rates of hospital-acquired Pseudomonas was 59% to amikacin, less than
50% to other antibiotics. The susceptibility rates of community-ac-
quired coagulase(—) staphylococcus was 91% to cephalothin, 63% to
gentamicin, but less than 60% to other antibiotics. The susceptibility
rates of Enterococcus was more than 80% to ampicillin, but less than
60% to penicillin. 7) In 1987 and 1988, the susceptibility to of toxacin
among 60 cases with gram(—) rods was 96%.
Clinical study on 740 cases of acute pyelonephritis (1980—1989). H.S.
Son, T.W. Lee, C.K. Ihm, and M.J. Kim, Department of Internal
Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
The retrospective clinical study was performed in 740 cases of acute
pyelonephritis during the preceding 10 years from Jan. 1980 to Dec.
1989. The sex distribution was 51 cases in male and 689 cases in female;
the ratiO of male to female was 1:13.5. The age distribution was 241
cases (46.1%) in third decade, 121 cases (16.4%) in 4th decade, and 100
cases (13.5%) in 5th decade. The highest incidence of acute pyelone-
phritis in male was 5th decade (14 cases, 27.5%). The underlying
diseases were recognized in 279 of 739 cases (37.8%). In males, these
were stones (21.5%), DM (5.9%), prostatic hypertrophy (5.9%), and
instrumentation (2.0%). In females, these were pregnancy (16.9%), DM
(4.9%), stones (4.5%), and congenital anomalies (2.5%). In clinical
manifestations, the most common symptom was fever and chill (92.0%),
followed by flank pain (60.4%), nausea (41.4%), frequency (39.2%), and
headache (39.0%). From the date of treatment, fever subsided within 7
days in 89.8% in patients with complicated infections and in 93.5% in
uncomplicated infections. On I.V.P. normal findings were noted in 178
cases (65.9%) and abnormal findings such as renal stones (7.4%), faint
visualization (6.4%) and ureteral stricture (4.8%) in 92 cases (34.1%).
On urinalysis, pyuria (>5 WBC/HPF) was noticed in 87.6%, micro-
scopic hematuria (>5 RBC/HPF) in 32.6%, and proteinuria (>(±) by
dipstick method) in 81.3%. On urine culture, causative organisms were
isolated in 395 cases (53.4%). The most common causative organism
was E. co/i (81.6%), followed by pseudomonas (6.6%), and staphylo-
coccus (3.8%). The most common organism was E. coli (84.5%) in
female and pseudomonas (50%) in male. In sensitivity tests of isolated
organism to antibiotics, they were sensitive to amikacin (88.6%),
gentamicin (84.3%), pipemidic acid (81.5%). E. co/i showed the sensi-
tivity of 97.8% to amikacin, 96.9% to pipemidic acid, 95.9% to genta-
micin (95.9%). On blood culture, causative organisms were isolated in
37 of 502 cases (7.4%), 11.1% in males, and 7.4% in females and isolated
organisms were E. co/i (34 cases, 91.9%) and pseudomonas (3 cases,
8.1%). In yearly distribution of causative organisms, there were no
consistent trends. Recurrent infections were developed in 50 cases
(6.8%) and these were mostly reinfection. Recurrent infections were
developed in 22 of 132 cases (16.3%) in complicated infection, and 28 of
548 cases (4.6%) in uncomplicated infection.
Organisms and antibiotic sensitivity in the urinary tract infection. J. T.
Cho, W.S. Yang, Y.G. Kim, J.S. Han, S. Kim, and J.S. Lee, Depart-
ment of Internal Medicine, Seoul National University College of
Medicine, Seoul, Korea. To guide the selection of empirical antibiotics
properly, we analyzed organisms and antibiotic sensitivity in urinary
tract infectiOn which was defined as urine culture growths above l0
CFU/ml. The records of all patients at the Seoul National University
Hospital between January and December 1989 who had urinary tract
infection were reviewed. In the 1,542 urine culture growths, mean age
was 49 17 (mean SD), female to male ratio was 55:45, and the total
number of organisms were 54, of which E. co/i was 27%, coagulase-
negative staphylococci was 16%. There were significant differences of
mean age, sex, and departments according to organisms. Eighty-five
percent of E. coli was female, and 64% of coagulase-negative staphylo-
cocci was male. In the antibiotic sensitivity of each organism, E. co/i
was 84%, 65%, and 33% sensitive to gentamicin, cephalothin, and
ampicillin, respectively, and coagulase-negative staphylococci was
90%, 59%, and 20% sensitive to cephalothin, gentamicin, and ampicil-
lin, respectively. The mean antibiotic sensitivity, which was defined as
mean of all scores of tested antibiotics (sensitive was scored as 1,
intermediate as 0.5, resistent as 0), had significant differences according
to the organisms, age, sex, and departments (P < 0.05) that females, 30
to 50 decades of age, and OPD were more sensitive than males, 60 to 70
decades of age, and ward respectively, but in consideration of organ-
ism's differences, there was no significant difference according to the
age, sex, and departments.
Evaluation of diagnostic tools for urinary tract infection in pediatric
patients. K.S. Pai, J.S. Lee, and P.-K. Kim, Department of Pediatrics,
Yonsei University College of Medicine, Seoul, Korea. To distinguish
between upper and lower urinary tract infection (UTI), the authors
measured urinary excretion and renal clearance of 132 microglobin
(f32m). In upper UTI patients (N = 11), the average serum f32m level was
3.27 2.39 mg/liter and the 24-hour urinary excretion of fJ2m was 3.74
7.89 mg/24 hr, both of which were significantly increased over those
of lower UT! patients (N = 12, 1.18 0.41 mg/liter, 0.084 0.05 mg/24
hr). Four radiological studies: intravenous pyelography (IVP), sonog-
raphy, voiding cystourethrogram (VCUG), and mTcdimercaptosuc
cinic acid (DMSA) scan, were all performed in thirty patients out of 198
UT! cases, those which were diagnosed in the hospital from Mar. 1986
to Feb. 1989. Abnormal findings were observed in 18 cases (60%) by
IVP, 14 cases (47%) by sonography, 6 cases (20%) by VCUG, and 22
cases (73%) by DMSA scan. With respect to age group, 3 cases (36%)
were detected by IVP in the <1 yr age group, but 9 cases (75%) were
detected in the 6 to 15 years of age group. IVP was more diagnostic for
the older age group. Sonography and DMSA scan showed the same
results, but VCUG did not show a significant difference with regard to
age group. In 23 patients with reflux confirmed by VCUG, IVP revealed
hydronephrosis and/or hydroureter; 33 (72%), UPJ stenosis; 24 (52%),
clubbing calyx 18 (39%), impaired renal function; 16 (35%), abnormal
UVJ site; 16 (35%), cortical scar; 16 (35%), change in kidney size; 12
(26%), and UVJ stenosis 3 (7%). In 45 patients without reflux, IVP
revealed abnormal UVJ site; 21 (23%), hydronephrosis; 20 (22%),
pelviectasis; 17 (19%), UPJ stenosis; 14 (16%), clubbing calyx; 13
(14%), change in kidney size; 10 (11%), impaired renal function; 9
(10%), and cortical scar; 6 (7%).
Urinary tract infection in high risk neonates. Hf. Choi, Y.S. Ko, and
S.J. Lee, Department of Pediatrics, College of Medicine, Ewha Wom-
an's University, Korea. Early diagnosis and treatment of urinary tract
infection is essential because it is often associated with major urinary
tract anomaly and renal scarring. To verify bacteriuria, suprapubic
aspiration has been recommended to avoid the contamination of urine.
We screened the bacteriuria in 792 high risk neonates from May 1987 to
May 1990 to assess the incidence and characteristics of UT! in high risk
neonates and to decide whether screening for bacteriuria is justified in
this population. The results were as follows: 1.) The incidence of UTI,
verified by suprapubic aspiration was 1.9% (15/792). 2.) There were the
significant differences (P < 0.05) between male (2.8%) and female
(0.6%), symptomatic (3.6%) and asymptomatic (0.9%) high risk neo-
nates. 3.) The false positive rates of first or second bag urine cultures
were very high (96, 76%). 4.) The identified organisms were E. co/i (6),
Klebsiella pnëumoniae (4), Enterobacter (2), Coagulase negative staph-
ylococcus, and candida albicans (1). 5.) Radiologic abnormalities were
identified in 5 cases (0.6%), UPJ obstruction in one, VUR in three and
fungus ball in one. All need medical or surgical intervention. In
conclusion, screening for bacteriuria in high risk neonates would be
beneficial for early diagnosis of UTI and detection of major urinary tract
anomalies.
Radiologic evaluation in children with urinary tract infection. M.H.
Kim and S.J. Lee, Korea. Radiologic evaluation of urinary tract is
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essential because UTI in children is usually a first presenting sign of
urinary tract anomaly. Early diagnosis and treatment of major urinary
tract anomalies are important to prevent renal damage. There is still
considerable disagreement as to what investigation should be under-
taken. Until several years ago, IVP and VCUG were included as routine
tests in all children after the first or second UTI. Recent studies indicate
that ultrasound can effectively replace IVP as a screening procedure,
and Tc-DMSA scan is more sensitive than IVP for detection of early
stage of renal scarring and predictability of VUR. We performed the
various radiologic examinations in 142 children, diagnosed as the first
UT! in Pediatric department of E.W.U.H. from March 1984 to March
1990, and compared the results retrospectively. The results were as
follows. 1.) Radiologic abnormalities were observed in 42 of 142
children (29.6%), 30 of 101 male (29.7%) and 12 of4l female (29.2%). 2.)
Radiologic abnormalities were primary vesicoureteral reflux in 22
(15.5%), ureteropelvic juction obstruction in 6 (4.2%), non-obstructing
non-refluxing megaureter in 3 (2.1%), stones in 3 (2.1%), ureterovesical
junctinnaistrjcticmJn(.L4%).po.sturethr.aLv.ah'e. hJadd div.erticjL-
lum, single kidney, hypoplastic kidney, duplication, and ectopic ureter
in 1 each. 3.) Primary vesicoureteral reflux could be confirmed only by
VCUG. 4.) Obstructive uropathies were diagnosed by US and Tc-
DTPA scan with renogram and relieved by surgical intervention. Renal
stone was diagnosed by US but two ureter stones by KUB. Posterior
urethral valve and bladder diverticulum were confirmed by YCUG. 5.)
Cortical defects were observed in 12 of 32 (37.5%) on initial Tc-DMSA
scan but persisted only in 7 of 10 (70.0%) in the follow-up scan, which
was done 6 weeks later. Detection rate of renal scarring by IVP was
only 7.0% (6/86). 6.) Ectopic ureter is the one that could be diagnosed
only by IVP. In summary, we think we can detect major urinary tract
anomalies and renal scarring with more accuracy and less radiation if
we perform KUB, US, and Tc-DMSA scan in acute stage, VUR in 2
weeks and follow-up Tc-DMSA scan in 6 weeks. If hydronephrosis and
hydroureter are observed, Tc-DTPA scan with renogram confirm the
obstruction. IVP will be indicated in some cases to delineate the
morphology.
Clinical studies on 123 cases of urinary tract infection in renal
transplant recipients. HI. Yang, T. W. Lee, C.G. Ihm, and M.J. Kim,
Department of Internal Medicine, Kyung Hee University School of
Medicine, Seoul, Korea. A retrospective clinical evaluation was per-
formed on 123 cases of urinary tract infection (UT!) in renal transplant
recipients from August 1978 to August 1989, and following results were
obtained. Of 123 renal transplant recipients, 70 patients experienced
urinary tract infection (once, 42%; twice, 17.1%; thrice, 8.6%; four
times, 14.3%). UT! occurred within first 6 months of post-transplanta-
tion in 82.9% (first 1 month, 75.7%; 2 to 3 months, 5.7%; 4 to 6 months,
1.4%). UT! occurred in 41 among 86 (47.7%) male transplant recipients
and 29 among 37 females (78.4%). One half of the UT! patients had a
fever above 37.5°C, 9 cases of them (25.7%) above 38°C without
evidence of other organ infection or graft rejection. Associated bacte-
remia was noted in 3 cases of the patients with UT! (4.3%). Most
common causative organism was pseudomonas (13.0%) followed by E.
coli (9.5%), S. aureus (8.3%), klebsiella (6.0%), staphylococcus spp.
(6.0%) and candida (2.8%). In antimicrobial sensitivity tests, E. coli was
sensitive to AMK and GM, and was relatively resistant to other
antibiotics such as AMP, CB, CM, KM, SPT, and CF. Sensitivity of
pseudomonas to AMK was 63.6% and less sensitive to other antibiotics
such as AMP, CB, CM, KM, GM, SPT, and CF. The occurrence of UT!
in PDL + IMUR group was 65.0%, 69.4% in CsA + PDL group, and
55.5% in PDL + IMUR + CsA group. On the culture of Foley catheter
tip removed after 5 days of transplantation, organisms were isolated in
27 of 40 samples (65.9%) and the isolated organisms were E. coli,
staphylococcus spp., and streptococcus fecalis.
Clinical consideration of 7 patients with emphysematous pyelone-
phritis. J.H. Lee, S.K. Rhee, S.H. Shin, G.W. Yi, Y.T. Shin, and Y.K.
Kim, Department of Internal Medicine and Department of Urology,
College of Medicine, Chungnam National University, Daejeon, Korea.
Emphysematous pyelonephritis is a rare, poorly prognostic infection of
kidney associated with spontaneous generation of gas in renal paren-
chyme. !t is developed mostly in diabetics with or without urinary tract
obstruction. We reviewed 7 cases of emphysematous pyelonephritis
seen at the Department of !nternal Medicine, Chungnam National
University Hospital from March 1982 to May 1988. The results were as
follows. 1.) The mean age was 50 years old (range: 43—55) and male to
female ratio was 1:6. 2.) The frequent and pertinent symptoms and signs
were fever and chills, flank pain, rigors, nausea and vomiting, abdom-
inal pain, CVA tenderness, alteration of mentality and subcutaneous
crepitus, respectively, in order of frequency. 3.) The underlying disease
was diabetics in all patients, and urinary tract obstruction or congenital
anomaly was not detected. Two patients had been treated with insulin
and the others had not been treated. 4.) The site of lesion were right side
in 4 cases, left side in 2 cases and both sides in one case. 5.) The
important laboratory findings for diagnosis were marked leukocytosis,
pyuria, glucosuria, proteinuria, hematuria and elevated blood urea
nitrogen and creatinine. 6.) !n 4 cases, perinephric gas shadow was seen
on KUB. In 3 other cases, mottling or semilunar pattern of gas shadow
was seen on ultrasonogram or computerized tomogram of kidney. 7.)
The etiologic microorganisms were E. coli in 3 cases, Klebsiella
pneumoniae in 3 cases and Klebsiella ozaenae in 1 case. 8.) Treatment
cmius.tecl of conttoiling.. 'if hlnnd sugal wilk tegulat insulin OL NPR,.
maintenance of fluid electrolyte balance and administration of antibiot-
ics. !n 6 cases among them operations were done (nephrectomy: 3
cases, incision & drainage: 3 cases). One case died of septisemia and
the others were discharged with improvement.
Clinical study of vesicoureteral reflux in childhood. Y.S. Park, HI.
Cheong, Y. Choi, K. W. Ko, and H. Choi, Department of Pediatrics and
Department of Urology, Seoul National University, College of Medi-
cine, Seoul, Korea. Vesicoureteral reflux is the reflux of urine from the
bladder to the ureter due to the anatomical or functional defect of the
ureterovesical junction. This reflux leads to reflux nephropathy, which
is the most common cause of the chronic renal failure or hypertension
in the children. During the period from Jan. 1981 to Dec. 1988, there had
been 87 children who were diagnosed with voiding cystourethrography
as vesicoureteral reflux without accompanying other urogenital anom-
alies, in the Department of Pediatrics or Pediatric Urology, Seoul
National University Children's Hospital. Their clinical findings were
analyzed retrospectively and the results were as follows: 1) !n 87 cases
studied, 60 cases had bilateral reflux. Thus, 147 refluxing renal units
were demonstrated. 2) The mean age at the detection of vesicoureteral
reflux was 3.1 2.7 years and the male to female ratio was 2:1. About
a half of cases were detected before 2 years of age, and there was a
marked male preponderance in this group. On the other hand, there was
a some female preponderance in the remalning a half of cases detected
after 2 years of age. 3) Renal scarring was detected in 64 (48.1%)
refluxing renal units among 133 investigated. And the incidence of renal
scarring showed a tendency of a direct correlation with the severity of
vesicoureteral reflux. 4) There were no significant differences in the
severity of vesicoureteral reflux or in the incidence of accompanying
renal scarring according to the age at the detection of vesicoureteral
reflux. 5) The incidence of urinary tract infection was not related to the
severity of vesicoureteral reflux. However, the incidence of renal
scarring tended to increase according to the number of urinary tract
infections before the diagnosis of vesicoureteral reflux. 6) Proteinuria
was detected in 9 cases, among them, 7 cases revealed decreased renal
function and 3 cases progressed into end-stage renal disease thereafter.
7) Although the incidence of urinary tract infection during follow-up
was not different between the group with medical management and
those with surgical management, the incidence of pyelonephritis in the
urinary tract infection seemed to be higher in the group with medical
management than those with surgical management. 8) The spontaneous
disappearance rate of vesicoureteral reflux during follow-up seemed to
be higher in cases with milder grade of reflux. !n conclusion, the grade
of vesicoureteral reflux was not correlated with the incidence of urinary
tract infection, and vice versa. However, the grade of vesicoureteral
reflux and the incidence of urinary tract infection seemed to take an
important role in the formation of renal scars. The medical and surgical
management made little differences from each other in so far as the
incidence of urinary tract infection during follow-up was concerned;
however, the incidence of pyelonephritis seemed to be higher in the
group with medical management. And the presence of proteinuria was
an ominous sign predicting deterioration of renal function.
Gram negative peritonitis in CAPD: Clinical manifestations and out-
comes. S.K. Lee, D.C. Han, M.S. Park, S.D. Hwang, and H.B. Lee,
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Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul,
Korea. Peritonitis by gram negative (G—) organisms, particularly
Pseudomonas (P), suggest intraabdominal pathology necessitating early
removal of catheter and/or abdominal exploration. We compared the
clinical manifestations and the outcomes between 46 episodes of G—
and 100 episodes of gram positive (G+) peritonitis that occurred within
the past 2 years. G— peritonitis were caused by P. aeruginosa (12
episodes), Acinetobacter (8), Serratia (7), other P. species (6), E. coli
(4), Klebsiella (3), and others (2). G+ peritonitis were caused by S.
aureus (43 episodes), S. epidermidis (38), streptococcus (8), and others
(11). G— peritonitis was associated with significantly higher initial
leukocyte count of drained dialysate (7,839 vs. 3,344/mm3) and higher
incidence of admission to hospital (34/45 vs. 42/100), catheter removal
(22/46 vs. 17/100), serious complications, that is, sepsis, intraabdominal
abscess and intestinal obstruction (11/46 vs. 5/100), and death (5/46 vs.
1/100) when compared to G+ peritonitis. P. aeruginosa peritonitis was
associated with significantly higher incidence of fever (10/12 vs. 8/34),
serious complications (7/12 vs. 4/34), catheter removal (10/12 vs. 12/34)
and death (5/12 vs. 0/34) when compared to other G— peritonitis. In
conclusion, G— peritonitis in general and P. aeruginosa peritonitis in
particular is associated with significantly higher morbidity and mortality
than peritonitis by G+ organisms.
Fungal peritonitis complicating continuous ambulatory peritoneal dial-
ysis patients. S.B. Park, W.K. Lee, K.W. Lee, H.C. Kim, andj.R. Kim,
Department of Internal Medicine and Department of Clinical Pathol-
ogy, Keimyung University School of Medicine, Taegu, Korea. Seven-
teen cases of fungal peritonitis were observed in 110 patients during the
first 5 years of our continuous ambulatory peritoneal dialysis (CAPD)
program. Fourteen cases (82.4%) were isolated Candida species.
Among them C. parapsilosis, C. albicans and C. guillermondii were
frequently found. Remaining causative fungi were Saccharomyces
cerevisiae, Penicillium species, and Trichosporon cutaneum. Fungal
peritonitis had the same clinical features as bacterial peritonitis. But
numerous colonizations were showed on the lumen of catheters in most
of the cases. Antifungal agents used were amphotericin B intrave-
nously, oral ketoconazole and flucytosine. Fourteen cases were treated
with removal of catheter and 2 cases were treated without catheter
removal. There were eight deaths associated with fungal peritonitis.
Two cases were retried on CAPD and one of these patients suffered
recurrent fungal peritonitis. One case of fungal peritonitis was improved
without removing the catheter and another case was improved after
catheter replacement with antifungal agents.
Radionucide peritoneal seintigraphy in CAPD. D.G. Shin, T.W.
Kwon, S.H. Kim, D.K. Cho, J.T. Lee, and K.B. Lee, Department of
Internal Medicine and Department of Nuclear Medicine, College of
Medicine, Kyungpook University, Taegu, Korea. Thirty-four CAPD
patients underwent peritoneal scintigraphy utilizing mTcsulfur col-
bid. Patients were divided into three groups. Group 1(23 cases) had no
complications secondary to CAPD. In twenty of these, radiocolloid was
distributed evenly after the end of the infusion, and the even distribu-
tion was maintained throughout the whole dwelling time. Average
recovery rate of radioactivity from drained dialysate was 70.7%. Three
of group 1 had poor radiocolloid recovery rate (21%) and their scinti-
gram showed multifocal accumulation of radiocolloid after 3 hours of
ambulation and in post-evacuation images. Its clinical significance was
undetermined. Group 2 (6 cases) had abnormal physical findings pre-
sented as external genital swelling (3), abdominal wall swelling (2), or
leakage from exit-site (1). Scintigrams were abnormal in two patients
with genital swelling and provided localizing information that aided in
the management of leakage. In one instance of abdominal wall swelling,
peritoneal scintigraphy demonstrated leakage from the previous oper-
ation site. Group 3 (5 cases) consisted of patients with recurrent
peritonitis. Scintigrams were normal in all patients. No side effects or
complications associated with the technique were observed. In conclu-
sion, peritoneal scintigraphy with radiocolboid is a safe, non-invasive
method of imaging of the peritoneal cavity and can be used effectively
for the assessment of complications related to CAPD procedure.
Clinical observation of 180 living renal transplants. S.H. Lee, W.J.
Choi, S.H. Yang, H.K. Kim, S.R. Lee, S.D. Lee, and H. 1'. Rhew,
Department of Internal Medicine, General Surgery and Urology, Kosin
Medical College, Pusan, Korea. We reviewed 180 cases of renal
transplantation done by Kosin Medical College kidney transplantation
team from December 1984 to February 1990. The mean age of donors
and recipients was 38.5 years and 32.1 years, respectively, and male to
female ratio was 1: 1.2 in donors and 2.3:1 in recipients. Twenty-five
cases were HLA-identical (HLA-ID), 122 cases were HLA-haploiden-
tical (HLA-HID), 4 cases were HLA-nonidentical (HLA-NID), 29
cases were living unrelated (LUR). Among HLA-HID patients, 23
cases were given azathioprine plus prednisolone (Aza + P) and 89 cases
were given cycbosporine A plus prednisolone (CsA + P). 3 year graft
survival rate among the recipients with HLA-DRw6 was 74.8% vs.
87.6% without HLA-DRw6 (P> 0.05). In living unrelated groups, 3
year graft survival rate was not significantly different between 3 MM
(Mismatch) group and 4 MM group of HLA-A,B antigens (67.8% vs.
100%; P > 0.05). And it was not significantly different between 1 MM
group and 2 MM group of HLA-DR antigens (100% vs. 83.3%; P>
0.05). In HLA-HID group, 3 year graft survival rate was 100% for
patients with S.I. less than 2.0, 89.4% for patients with S.I. above 2.0 (P
> 0.05), but R.R. did not significantly affect the graft survival rate.
Acute rejections developed in 4 cases (17.4%) in the HLA-ID group, 9
cases (39.1%) in the Aza + P treated HLA-HID group, 35 cases (39.3%)
in the CsA + P treated HLA-HID group, 2 cases (50%) in HLA-NID
group and 11 cases (39.3%) in LUR group. But the differences among
these groups were not significant. Graft loss occurred in 26 cases
(14.4%) whose causes were chronic rejection in 10 (38.5%), accelerated
acute rejection in 3 (11.5%), poor drug compliance in 3 (11.5%) and
others in 10 (38.4%). Serum creatinine over 2 mg/dl were observed in 2
cases (8.7%) in HLA-ID group, 6 (26.1%) in Aza + P treated HLA-HID
group, 26 (29.2%) in CsA + P treated HLA-HID group, 2 (50%) in
HLA-NID group and 3(10.7%) in LUR group, but the differences were
not significant. The cumulative 3 year graft survival rate was 90% in
HLA-ID group, 86% in HLA-HID group, 71% in HLA-NID group and
86% in LUR group. Again, the differences among these groups were not
significant. Overall 3 year patient survival rate was 98%.
Cell-mediated immunity in chronic renal fallure inhibition of blasto.
genesis and interleukin-2 (LL-2) of production by uremic serum. K.H.
Chol, Y.K. Kim, S.K. Ha, H. Y. Lee, D.S. Han, B.K. Lee, and J.D.
Kim, Department of Internal Medicine and Department of Microbiol-
ogy, Yonsei University College of Medicine, Seoul, Korea. To elucidate
the presence of humoral factor as an explanation for immunosuppres-
sion in chronic renal failure, we compared the effect of sera on the
lymphocyte mitogenic response and IL-2 production following phyto-
hemagglutinin (PHA) stimulation, mixed lymphocyte culture response
and natural killer (NK) cell activity from 103 ESRD patients (45
predialysis uremic, 33 hemodialysis, 25 continuous ambulatory perito-
neal dialysis) and 62 healthy individuals. When lymphocyte cultures
were performed in fetal calf sera, there were no significant differences
of blastogenesis and IL-2 production expressed in cpm between control
and ESRD patients (means SE, cpm, 6255.9 2103.2 vs. 5784.2
1977.8, 2677.5 336.4 vs. 2432.7 223.7, F> 0.05). However, in the
presence of uremic serum, the value of blastogenic response and IL-2
production in both groups were markedly lower than those in normal
serum (proliferation index, 1.101 0.15vs. 0.66 0.06, 0.93 0.llvs.
0.54 0.07, IL-2: 2914.0 332.0 vs. 1810.0 239.0, 2241.3 195.6 vs.
1506.0 201.8, P < 0.05, respectively). No significant differences in
mitogenic repsonse or IL-2 production between control and ESRD
patients were noted when respective lymphocytes were exposed to
same sera, and patients' sera did not have a remarkably suppressive
influence on mixed lymphocyte culture response or NK cell activity (P
> 0.05). It can be concluded that serum from ESRD patient does have
suppressive activity on PHA induced mitogenesis as well as IL-2
production of lymphocyte and these immunologic alterations is attrib-
utable in unknown factor(s) in uremic sera, rather than lymphocyte per
se.
Lymphocyte monitoring by flow cytometry in renal transplantation.
H.B. Lee, C.S. Park, M.S. Park, D.C. Han, S.K. Lee, S.D. Hwang,
and C. Moon, Hyonam Kidney Laboratory, Soon Chun Hyang Univer-
sity, Seoul, Korea. We monitored peripheral blood lymphocyte (PBL)
subsets by flow cytometry from 2 days before till 14 days after renal
transplantation (KTx) in 19 patients to better understand immune
responses early after KTx. One patient lost graft from hyperacute
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rejection and 3 had acute cellular rejection during the first 14 days after
KTx. All patients received azathioprine and prednisolone (PDL) for 2
days before and cyclosporine A (CsA) and PDL after KTx. In 15
patients with no rejection PBL count increased from 1,034/mm3 on day
0 to 2,574 and 2,106 on days 7 and 14, respectively. Fraction of T3 and
T4 increased and T8 decreased after KTx. T4/T8 ratio, therefore,
increased significantly after KTx. NK cell (anti-Leu llb+) and B cell
(anti-human IgM+) fractions remained unchanged. Ia expression (anti-
HLA DR+) of PBL decreased significantly after KTx. IL-2 receptor
expression (anti-Tac+) of PBL also decreased after KTx. In the patient
with hyperacute rejection Ia expression of PBL was very high on day 0
(46.0%) and remained elevated after KTx. B cell fraction was again very
high in this patient 2 days after KTx (14.4%). No consistent deviations
were observed in 3 patients with acute rejection. The dissection of T
cell subsets into cytotoxic, suppressor, helper, inducer and various
phenotypes responsible for natural killing is now possible and may
better correlate numerical changes with functional activity of lympho-
cytes in KTx.
Clinical analysis of post-transplant diabetes in renal transplant recipi-
ents. S.-A. Yoon, H.-J. Kim, H.-E. Kim, Y.-S. Kim, Y.-S. Yoon, and
B.-K. Bang, Department of Internal Medicine, Catholic University
Medical College, Seoul, Korea. We retrospectively reviewed the
course of 445 renal transplants who received transplants between Mar.
1969 and Feb. 1990 at CMC, to assess the clinical characteristics of
post-transplant diabetes mellitus (PTDM). The 445 transplants con-
sisted of 331 men and 114 women who had age range of 14 to 59; 433
primary transplants and 12 retransplants; 12 CAD, 297 LRD, 136 NRD;
147 azathioprine (Aza) + prednisolone (PDN) - and 298 cyclosporine(CsA) + PDN - treated patients. The overall incidence of PTDM was
8.3% (N = 37; 6.8% in Aza + PDN; 9.1% in CsA + PDN), which was
higher than that of diabetes (3.5%) in Korean population (P < 0.01). The
onset of PTDM varied from postoperative 1 month to 108 months
(median: 3 months). At the diagnosis of PTDM the mean values of FBS,
PPS 2 hrs and serum Cr. were 202 87 mg/dl, 297 58 mgldl and 1.6
0.8 mgIdl, respectively. At the time of operation the older recipients
(>40 years old) had higher incidence of PTDM (P < 0.05), but sex, type
of immunosuppressants and donor source were not associated with
significant risk for PTDM. There was no prevalent phenotype of
HLA-A, -B, -C and -DR antigens in PTDM patients. The actuarial
patient survival rates of Aza + PDN, CsA + PDN treated and PTDM
patients at 1 year were 82%, 98% and 100%, respectively. The corre-
sponding actuarial graft survival rates at 1 year were 76%, 93% and
100%, respectively. In conclusion, the older age at the time of operation
may be a risk factor for PTDM, and PTDM itself doesn't affect
adversely on graft survival rate after renal transplantation.
Serum electrolytes after renal transplantation. S.J. Park, C. W. Nam,
T. Y. Kim, S.H. Yang, H.K. Kim, and S.R. Lee, Department of Internal
Medicine, Kosin Medical College, Pusan, Korea. Among 187 kidney
transplantation cases performed by the Kosin Medical College kidney
transplantation team from December 1984 to March 1990, we reviewed
serum creatinine and electrolytes of 180 cases whose grafted kidney had
been functioning for at least 1 month. We investigated the changes of
serum creatinine and electrolytes according to immunosuppressants
and renal function. Serum Cr was 1.14 0.26 mg/dl (mean SD, N =
35) in Aza treated group and 1.56 1.03 mg/dl (N = 135) in CsA treated
group at 1 week after transplantation (P < 0.05). Serum Na in patients
with serum creatinine below 2 mg/dl was 140.83 2.53 mEq/liter ( N =
35) in Aza treated group and 139.38 3.05 mEq/liter (N = 126) in CsA
treated group at 4 weeks after transplantation (P < 0.05). Serum K in
patients with serum Cr below 2 mg/dl was 4.18 2.56 mEq/liter (N =
35) at 2 weeks and 4.05 0.57 mEq/liter (N = 22) at 1 year after
transplantation in Aza treated group vs. 4.41 0.61 mEq/liter (N =
127), 4.43 0.71 mEq/liter (N = 48), respectively in CsA treated group
(P < 0.05). Serum Ca in patients with serum Cr below 2 mg/dl was 4.58
0.46 mEq/liter (N = 32) in Aza treated group and 4.36 0.41
mEq/liter (N = 95) in CsA treated group at 4 weeks after transplantation(P < 0.05), but between 3 months and 1 year after transplantation,
serum Ca was higher in CsA treated group (P > 0.05). Transient
hypercalcemia was seen in 20 cases (11.1%). There was no significant
difference in serum P between Aza treated and CsA treated group.
Transient hypophosphatemia occurred in 88 cases (48.9%), which was
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observed at 3rd day in 53 cases (37.1%), at 7th day in 48 cases (32.6%)
and at 1 month in 19 cases (14.2%). Serum uric acid in patients with
serum Cr below 2 mg/dl was 5.96 1.16 mg/dl (N = 13) in Aza treated
group and 6.68 1.62 mg/dl (N = 53) in CsA treated group (P > 0.05).
Hyperuricemia was observed in I case (11.1%) in Aza treated group and
in 9 cases (17.0%) in CsA treated group. When Aza to CsA or CsA to
Aza conversion occurred in patients with normal renal function, serum
Cr was higher with administration of CsA (P> 0.05).
Therapeutic use of OKT3 for acute renal allograft rejection. Y.-S.
Yoon, Y.-S. Kim, 1.-S. Park, S.-Y. Kim, W.-S. Koo, Y.-W. Kim, B.-K.
Bang, and Y.-B. Koh, Department of Internal Medicine, Department of
General Surgery, Catholic University Medical College, Seoul, Korea.
The monoclonal antibody, OKT3, has been used to treat the initial
acute episode of rejection in the recipients of living donor renal
allografts. All patients who had no clinical improvement with pulse
methylprednisone received OKT3 5 mg daily for a period of 3 to 10
days, during which the cyclosporine and prednisone dosages were
sharply reduced. In all instances, the established rejection episode was
reversed in 3 to 8 days (mean 4.8 days). Only two recurrent rejection
episodes (20%) have been observed in the I to 13 month follow-up
period after OKT3 treatment; infection has occurred in one patient
(10%) and one graft (10%) has been lost 13 months after transplantation.
Fever, chills, nausea, vomiting and diarrhea were the most common
side effects. In conclusion, despite unresolved limitation for use,
clinical studies have subsequently demonstrated that OKT3 can suc-
cessfully reverses renal allograft rejection episodes in patients failing on
conventional immunotherapy regimens.
OKT3 monoclonal antibody use in pediatric renal transplantation.
Y.H. Park, J.L. Marik, and RB. Ettenger, Department of Pediatrics,
Yeungnam University Hospital, Taegu, Korea, and Division of Pediat-
ric Nephrology, UCLA School of Medicine, Los Angeles, California,
USA. In adult renal transplantation (Tx), OKT3 is useful both in the
prevention of rejection (rej) during induction therapy and in the
treatment of steroid-resistant rej, but its place in pediatric renal Tx is
not yet established. We evaluated the use of a first course of OKT3 in
pediatric Tx patients (pts) (mean age = 12.9 years); 12 of these pts were
<10 years old. Twenty-three received OKT3 for reverse or steroid
resistant rej (Grp 1) and 20 received it as induction therapy (Grp 2). Of
23 Grp 1 pts, OKT3 reversed rej in 21 (91%). Two pts (8%) with
vascular rej did not respond and had immediate Tx failure. Of the 21
Grp 1 pts who respond maintenance cyclosporine (CsA) adjustment and
careful monitoring resulted in only I additional pt having rebound rej
occurred when the pt was noncompliant with her CsA. Two pts lost
graft function at 2 and 5 months after OKT3 from chronic rej, for a one
year graft survival rate of 83%. Nine infectious complications occurred
in 7 Grp I pts (30%): 4 episodes of CMV infection, 4 episodes of herpes
stomatitis and I episode of E. coli urinary tract infection (UTI). Grp 2
pts, 2 (10%) lost their Tx: one at 6 months because of recurrence of the
nephrotic syndrome and one at 3 days because of unexplained death
with a well-functioning Tx. All other Grp 2 Tx function well for 2 to 11
mos. Five episodes of infection occurred in 4 pts (20%): 2 candida UT!,
1 bacterial pneumonia, 1 bacterial UTI and 1 CMV disease. Anti-OKT3
antibodies (abs) developed in 15 of 33 pts tested (45%); in Grp 1,7 of 14
pts (50%) developed ab while in Grp 2, 8 of 19 (42%) developed ab.
There was no difference between Grp 1 and 2 when comparing the
proportion of pts developing high titer ab. We conclude that OKT3 is
very effective in pediatric renal transplantation for both rej reversal and
induction therapy. The incidence of infectious complications and ad-
verse anti-OKT3 ab are no more frequent in children receiving OKT3
for pophylaxis than in those receiving it for rej reversal.
Infectious complications after renal transplantation. D.H. Choi, K.J.
Kang, K.W. Kim, C.H. Moon, D.C. Han, MS. Park, S.K. Lee, J.H.
Woo, C. Moon, andH.B. Lee, Hyonam Kidney Laboratory, Soon Chun
Hyang University, Seoul, Korea. Infection continues to contribute
substantially to the morbidity and mortality of renal transplantation
(KTx). We evaluated the incidence, causative organisms, site and time
of infection and mortality directly related to infection in 96 patients who
were transplanted between 1980 and 1990. Forty-two patients received
azathioprine (AZA) and 54 received cyclosporine A (CsA) in addition to
steroid. A total of 66 episodes of infection were diagnosed in 45 of 96
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patients (46.9%). Organisms were isolated in 29 episodes: bacteria in 26,
fungi in 2 (one each of aspergillus and crypotococcus) and protozoa
(Pneumocystis carinii) in one episode. In the remaining 37 episodes
including 10 episodes of viral infection (herpes zoster in 7, herpes
simplex in 2, CMV in 1) and 2 episodes of pulmonary tuberculosis the
diagnosis was made by clinical or serological data, Site of infection
included urinary tract (25 episodes), skin and soft tissue (20), lung (9),
blood (6) and others (3). Site was unknown in 3 episodes. Infection was
diagnosed within one month of KTx in 15 episodes, between one and 6
months in 26 episodes and after 6 months in 25 episodes. Twelve of 96
patients (12.5%) died and in 9 of these 12 patients (75.0%) the death was
directly linked to infection. Fatal infections occurred within one month
of KTx in one, between one and 6 months in 3 and after 6 months in 5
patients. Incidence of fatal infection was lower in CsA-treated than in
AZA-treated patients (2/54 vs. 7/42). In conclusion, infection remains
the most common cause of morbidity and mortality in KTx. CsA
appears to reduce the incidence of fatal infection.
Evaluation of urine acidification by urine anion gap. G.H. Kim, J.H.
Earm, J.S. Han, S. Kim, and J.S. Lee, Seoul National University
College of Medicine, Seoul, Korea. Urine acidification of the distal
renal tubule can be evaluated with the urine ammonium excretion.
Recently urine anion gap was known to be a useful index of urine
ammonium, but its detailed clinical significance and relationship with
other urine acidification indices are not defined. To evaluate the
diagnostic value of urine anion gap and to observe its relationship with
other urine acidification indices in the presence of urine acidification
defect, we measured the urine anion gap (AG), urine ammonium,
titratable acidity (TA) and urine bicarbonate in 4 distal renal tubular
acidosis (RTA) patients, 8 end-stage renal disease (ESRD) patients, and
8 normal controls (NC) after acid loading with NH4CI 0.1 g/kg/day p.o.
for 3 days. The urine AG, urine ammonium, TA and urine bicarbonate
were measured by spot urine electrolyte concentrations, modified
Conway method, Folin's titration method, and blood gas analyzer,
respectively. 1.) Arterial bicarbonate concentrations were 19.6 1.7
mmol/liter (mean SE), 18.0 0.5 mmollliter, 11.6 0.8 mmol/liter inNC after acid kading di&taLSeivDaiiy
urine ammoniums were 56.3 3.7mmol, 22.5 3.1 mmol and 7.7 1.7
mmol in NC after acid loading, distal RTA and ESRD, respectively.
Daily urine TA's were 27.0 2.2 mmol, 0.4 0.3 mmol and 5.8 2.3
rnmol in NC after acid loading, distal RTA and ESRD, respectively.
The daily urine ammonium and TA's were smaller in distal RTA and
ESRD than in NC after acid loading (P < 0.05). 3.) Daily urine
bicarbonates were 0.1 0.2 mmol, 13.3 3.7 mmol and 3.0 1.0 mmol
in NC after acid loading, distal RTA and ESRD, respectively. The
larger daily urine bicarbonates were, the smaller daily urine TA's were.
4.) Urine anion gaps were 16.2 5.5 mmollliter, 48.8 11.3 mmol/liter
and 22.8 4.0 mmol/liter in NC after acid loading, distal RTA and
ESRD, respectively. They were higher in distal RTA and ESRD than in
NC after acid loading (P < 0.05). 5.) The urine anion gap was inversely
correlated with the urine ammonium in NC before and after acid loading
(r, =
—0.75, P < 0.01). 6.) In all the cases of distal RTA and ESRD with
urine AG more than 10 mmol/liter, daily urine ammonium excretions
were less than 30 mmol. We conclude that the urine anion gap reflected
the urine ammonium excretion and that the excretion of urine ammo-
nium was impaired when the urine anion gap was more than 10
mmol/liter in the presence of metabolic acidosis.
Three cases of idiopathic edema with metabolic alkalosis. S. Y. Lee,
S.K. Park, and S.K. Kong, Department of Internal Medicine, Chonbuk
National University, Medical School, Chonju, Chonbuk, Korea. Idio-
pathic edema is an ill-defined syndrome characterized by intermittent
edema secondary to sodium and water retention. It occurs almost
exclusively in women and is much worse on prolonged standing. In the
majority of women with idiopathic edema, symptoms are made worse
by diuretics and indeed may have been caused by diuretics, laxatives
and surreptitious vomiting (buliemia) that many of these women subject
themselves. The typical features of idiopathic edema are intermittent
swelling of the legs, hands with abdominal bloating. Thorn arbitualy
applied a criterion of a weight gain greater than 1.4 kg per day as
essential for a diagnosis. We encountered just such cases recently, and
herewith is our report of idiopathic edema with metabolic alkalosis.
Case presentation: 23-year-old female patient was admitted to our
hospital because of generalized edema and oliguria. She has been well
until 17 months ago when generalized edema developed. Ten months
prior to admission, oliguria developed and she started taking furo-
semide 80 mg a day. From 2 months prior to admission, she has been
taken 120 mg. But oliguria aggravated and sometimes voided 200 to 300
mI/day. Physical examination showed chronically ill, nervous woman
with mild puffy face. Urine amount for 24 hours was 200 ml. Laboratory
findings were normal except for hemoglobin 9.1 g%. PRA and aidoste-
rone level was 25.2 nglml/hr (0.15 to 2.33) and 4.49 ng/dl (1 to 16),
respectively. Furosemide was stopped. Body weight increased from
46.90 to 49.45 kg. Urine amount decreased but increased to 1000 ml
from 4 days after stopping. PRA and aldosterone level decreased to 0.84
nglml/hr and 13.2 ng/ml, respectively.
Laboratory findings of idiopathic edema on admission.
Case 1 Case 2 Case 3
(23,F) (27,F) (29,F)
Sodium mEq/liter 141 143 146
Potassium 3.8 2.9 3.5
pH 7.47 7.52 7.7
PRA ng/ml/hr 26.2 20.3 3.2
Aldosterone ng/ml 44.9 47.9 0.84
Urine Na mEqlliter 44,4 143 39
Urine volume cc/day 200 500 650
A clinical study in hospital inpatients with severe hyponatremia. J.H.
Choi, SW. Lee, Y.K. Kim, K.H. Choi, H.Y. Lee, and D.S. Han,
Department of Internal Medicine, Yonsei, University College of Med-
icine, Seoul, Korea. To determine the clinical characteristics and
outcome of severe hyponatremia seen in inpatients, we studied 49
patients (32 men, 17 women) with a serum sodium concentration of
under 125 mEq/liter on at least 2 occasions retrospectively. This
represented 0.18% of total admissions during the period. The patients
were aged 16 to 65 (mean: 52.2) years, and the serum sodium concen-
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the state of hydration, 26 patients (57%) showed hypervolemic hypona-
tremia, and normovolemic and hypovolemic hyponatremia was seen in
11(22.4%) and 12 (24.4%) patients. The common causes of hyper-
volemic hyponatremia were chronic renal failure (46. 1%), cirrhosis with
ascites (34.6%), and heart failure, in order. In normovolemic hypona-
tremia, 6 cases (54.5%) had malignant neoplasms including lung (33.3%)
and breast cancer, whereas there was no recognized cause of hypona-
tremia in 3 patients. Most of hypovolemic hyponatremia was attributed
to gastrointestinal hemorrhage or loss of salt and water (83.3%).
Although symptoms attributable to hyponatremia were nonspecific, the
hyponatremia was considered to be the cause of symptoms in 9 patients
(5.4%). The mortality rate was 38.7% (19/49 cases) and most deaths
were caused by underlying disease. With a serum sodium concentration
of 120 mEq/liter or less, the mortality rate was 47.3%, compared to
52.7% with concentration between 121 to 125 mEq/liter. From the
above results, it can be concluded that in severe hyponatremia ob-
served in admission patients, hypervolemic state associated with
chronic renal failure is more common, and the prognosis is largely
determined by the nature of the underlying disease.
Clinical characteristics of hypercalcemia. G.H. Kim, CS. Lim, J.S.
Han, S. Kim, and J.S. Lee, Department of Internal Medicine, Seoul
National University College of Medicine, Seoul, Korea. The causes of
hypercalcemia are various and its management is important when the
patient is symptomatic. Hypercalcemia produces derangements in the
function and structure of the kidneys depending on the duration and
degree of the hypercalcemia. To observe the underlying disorders,
symptoms, treatment modalities and renal effects of hypercalcemia we
performed a retrospective study on the patients admitted to the depart-
ment of Internal Medicine, Seoul National University Hospital in 1989,
whose serum ionized calcium levels were persistently elevated above
1.35 mmol/liter on at least two serial measurements. 1.) Of all the 50
cases, malignant tumors were 41 cases, of which lung cancer was the
most common and metastases were present in 21 cases. Benign diseases
were 9 cases, of which 4 cases with primary hyperparathyroidism, 2
cases with chronic renal failure, 1 case with hyperthyroidism and 2
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cases with unknown cause were observed. 2.) Main symptoms were
gastrointestinal such as anorexia and constipation, or neuromuscular
such as fatigue and weakness. Polyuria and polydipsia were in 4 cases,
and newly appeared hypertension was found in 2 cases. 3.) Serum
ionized calcium levels were below 2.5 mmol/liter in 46 cases. The
maximal value of serum ionized calcium was 2.68 mmol/liter of a patient
with lung cancer. 4.) Total serum calcium and phosphorus concentra-
tions were 12.6 1.5 (mean SD) mgldl and 3.3 1.0 mgldl,
respectively. 5.) 24-hour urine calcium amount and fractional excretion
of calcium measured in 9 cases were 581.0 281.6mg and 8.3 7.3%,
respectively. 6.) As for the renal effects of hypercalcemia, 4 cases of
acute renal failure, 8 cases of prerenal azotemia, 14 cases of impaired
urine concentration, 7 cases of urine acidification defect were observed.
7.) For the treatment of hypercalcemia, i.v. hydration with normal
saline plus i.v. furosemide was most commonly used. In other cases,
corticosteroid, calcitonin, or both were added.
Effects of nebulized salbutamol on hyperkalemia in patients with
chronic renal failure. K.J. Kim, T.W. Lee, C.G. Ihm, and M.J. Kim,
Department of Internal Medicine, Kyang Hee University School of
Medicine, Seoul, Korea. Hyperkalemia is a common medical problem
in chronic renal failure and must be treated immediately because it may
threaten life. It is known that f3-adrenergic agonist induces shifts of
potassium from ECF to ICF. It can be administrated by nebulizer,
which eliminates the need for establishing a vascular access. To
evaluate the effects of nebulized salbutamol, a /32-adrenergic agonist, on
plasma potassium concentration in patients with chronic renal failure,
we administered 10 mg or 20 mg of nebulized salbutamol and normal
saline alone to 10 patients on 3 different days. Serial plasma potassium
concentration, blood pressure and pulse rate were measured at 30-
minute interval for 2 hours. The results were as follows. After admin-
istration of nebulized normal saline alone, there was no significant
change of the plasma potassium concentration. (baseline: 5.53 mEq/
liter, after two hours: 5.46 mEq/liter) After administration of 10 mg of
nebulized salbutanol, there was no significant change of the plasma
potassium concentration. (baseline: 5.87 mEq/liter, after two hours:
5.58 mEq/liter) After administration of 20 mg of nebulized salbutamol,
plasma potassium concentration showed the tendency of decrease
within 30 minutes (P < 0.1), and the effects persisted for at least 2
hours. The maximal decrease in the potassium concentration was 0.89
0.30 mEq/liter. After nebulized administration of salbutamol, no
significant change of blood pressure and pulse rate was observed. In
conclusion, nebulized salbutamol therapy may be used as an alternate
modality for treating hyperkalemia in patients with chronic renal
failure.
Urinary tract infection in renal stones. S.K. Lee, T. W. Lee, C.G. ihm,
and M.J. Kim, Department of internal Medicine, Kyung Hee Univer-
sity School of Medicine, Seoul, Korea. To evaluate the relationships of
renal stones and urinary tract infection (UT!), we performed retrospec-
tive study in 126 patients with renal stone and UTI who visited to
Kyung Hee Medical Center during the past two years. The urine culture
were performed before one week and after one month of stone removal.
After stone removal procedure, antibiotic therapy was done for one
week. The results were as follows. The UTI was noticed in 126 among
436 patients with renal stones. The sex distribution was 89 cases in male
and 37 cases in female. The ratio of male to female was 3.4:1. The age
distribution was 43 cases (34.1%) in 4th decades and 39 cases (30.9%) in
5th decades, and were most frequently involved in 4th and 5th decades
(65%). On intravenous pyelography, the size of most stones was below
2 cm. Stones were detected most frequently in renal calyx (69%) and
renal ampulla (9.5%). The most common symptom was abdominal pain
and hematuria (65.1%), followed by fever (16.7%), and urinary fre-
quency (6.4%). The most commonly isolated organism was E. coli
(34.1%), followed by proteus t25:4%), k1ebsaiIFa(&-7%)-, cnter&buat
(7.1%), streptococcus (6.3%), enterococcus (4%), staphylococcus (4%),
pseudomonas (3.2%) in order. The sensitivity of E. coli to amkacin was
95.3%, to trimethoprim-sulfamethosazole 83.7% and to cephalosporine
79.1%. The four of 115 patients whose stone was completely removed
had persistent UT! after 1 month of stone removal. In the other II
patients with residual stones, all of them had persistent UTI after I
month of stone removal, which were caused by the same microbial
organisms as the pre-removal organisms except one patient.
The changes in urinary 2.microglobulin after antibiotic treatment in
upper urinary tract infection. Y.S. Hwang, T. W. Lee, C.G. Ihm, and
M.J. Kim, Department of internal Medicine, Kyung Hee University
School of Medicine, Seoul, Korea. p2-microglobulin is a low molecular
weight protein of 11,800 daltons, and about 95% of all free /32-
microglobulin is filtered by the normal glomerulus and subsequently
almost completely reabsorbed and catabolized by the cells of the
proximal tubules. As a result, malfunction of the proximal tubules will
be accompanied by a decreased tubular reabsorption and an increased
urinary excretion of /32-microglobulin, and measurement of urinary
excretion of /32-microglobulin has been reported a non-invasive and
specific method to distinguish between upper and lower urinary tract
infection. There are few reports about the changes of urinary 132-
microglobulin after antibiotic treatment in upper urinary tract infection.
So we measured the urinary /32-microglobulin before and after antibiotic
treatment in 10 patients with acute pyelonephritis. The results were as
follows.
1 2 3 4 5 6
At admission S-/32m mg/liter
U-/32m pg/liter
1.69 2.93
701 1695
3.04
1029
2.50 2.85 2.05
4000 465 606
In fifth S-132m mg/liter 1.34 2.08 2.93 2.13 2.08 1.67
hospital day U-132m pg/liter 1346 2088 2932 2135 2086 1676
7 8 9 10 Total
At admission 2.11 1.46
544 2034
2.41
1695
1.96
630
2.30 1.07
1339.3 691.4a
In fifth 1.65 2.60 1.17 1.64 1.93 1.09
hospital day 1654 2605 1173 1646 449.2 l15.2a
a P < 0.05
We conclude that the excretion of urinary f32-microglobulin is signifi-
cantly decreased in upper urinary tract infection after antibiotic treat-
ment.
Urinary tract infections after renal transplantation. S.B. Kim, J.S.
Lim, S.H. Yang, H.K. Kim, and SR. Lee, Department of Internal
Medicine, Kosin Medical College, Pusan, Korea. Among 187 cases of
kidney transplantation performed by Kosin Medical College kidney
transplantation team from December 1984 to March 1990, we reviewed
urinary tract infections of 180 cases whose grafted kidney had been
functioning for at least 1 month. Foley catheter was almost always
removed on the 7th post-operative day. For prophylaxis cefoperazone
was given 1 g twice a day for 7 days from the day of operation and
TMP/SMZ was given I6OTMP/800SMZ twice a day for 3 months after
discontinuation of cefoperazone. We defined UTt as bacteria or fungi
were cultured with concentration of at least 100,000 organisms/ml of
urine. The mean age of patients was 34.4 years and male to female ratio
was 2.2:1. The overall incidence of UT! was 22.9% and the total
episodes of UT! was 61 with 90% occurring during the first three
post-transplant months. In males 16.9% had at least one episode and
4.8% at least two episodes, while 26.3% and 13.1% females had one or
two episodes, respectively (P < 0.05). Patients over 50 years of age had
more common UT! with incidence of 60% vs. 20.5% in patients below
50 years. There were no significant differences among HLA-ID, HLA-
HID, HLA-NID and LUR groups, and no significant difference be-
tween CsA treated and Aza treated patients in HLA-HID group. UT!
occurred in 100% of patients with èhronic pyelonephritis and diabetic
nephropath.y .andi0% of oatients with reflux nephropathy. Grades of
vesicoureteral reflux of original urinary tract did not atfct iflcidenceof-
UTI except grade IV patients with incidence of 100%. The bacteria
were isolated in 77.8% of UTI. They were E. coli and Pseudomonas
each 14.2%, 5. faecalis and Acinetobacter each 9.5%, Citrobacter and
Kiebsiella each 6.3%. The fungi were cultured in 22.4% of UT!. Acute
rejections were observed in 46.3% of UT! patients and 22.7% of
non-UT! patients, and 15 episodes (42.8%) in UT! patients with acute
rejections occurred within 3 months before the rejection. After keto-
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conazole was given 200 mg twice a day for 7 days, CsA level increased
from 215.8 nglml to 722.7 ng/ml despite 1 mg/kg decrement of CsA (P <
0.05).
Removal of Amikacin in renal failure patients during continuous
arteriovenous hemofiltration. J.-G. Shin, J.-H. Uhm, S.-G. Shin, J.-S.
Han, S.W. Kim, and f-S. Lee., Clinical Pharmacology Unit, SNUH,
Department of Pharmacology and Nephrology, Seoul National Univer-
sity College of Medicine. The effect of continuous arteriovenous
hemofiltration (CAVH) on the kinetics of Amikacin was studied in
seven renal failure patients undergoing continuous ateriovenous hemo-
filtration. The average age and lean body weight of patients were 41.0
17.5 yrs and 58.7 8.0 kg, respectively. Pharmacokinetic parameters in
each patient were estimated by simulataneous measurement of peak
amikacin levels of arterial, venous plasma and filtrate samples, and
through arterial drug levels. Amickacin level in biological fluid was
measured by fluorscence polarizing immunoassay method. Average
clearance of amikacin by CAVH was 7.09 0.90 ml/min, which
corresponded to the 62.3 20.2% of total clearance during hemofiltra-
tion (filtration rate: 350 to 500 ml/hr). The sieving coefficient was 0.91
0.11 in the hemofiltration system of Gambro® AVH kit 55. Hemofiltra-
tion clearance (HFCL) was directly correlated with hemofiltration flow
rate (HFQR): HFCL = 1.0 + 0.829 x HFQR (r = 0.89). Volume of
distribution of Amikacin was estimated to be 0.32 0.07 liter/kg (lean
body weight). The half-lives of Amikacin in these renal failure patients
were significantly reduced by hemofiltration from 106.3 133.8 hr to
21.0 9.4 hr. The fraction of Amikacin removed in 24 hrs by CAVH
was estimated to be 35.86 7.68%. The present results suggest that
supplement dose and close monitoring of plasma Amikacin concentra-
tion is necessary for optimum Amikacin therapy during hemofiltration,
expecially in condition changing the filtration rate.
A study on the scoring system of the clinical severity in Korean
hemorrhagic fever (KHF). Y.G. Kim, D.J. Kim, J.S. Han, S. Kim, and
J.S. Lee, Seoul National University College of Medicine, Seoul, Korea.
Clinical course of KHF is variable from subclinical form, which is
difficult to diagnose before serologic confirmation, to severe one, which
leads to death. The severity of illness may be influenced by virulence of
the strain, host factors, and recently serotype of Hantavirus has been
found to be a factor. Classification of severity is important. We devised
a scoring system of severity with its own scoring items. To evaluate the
scoring systems with its merits and faults, we choose four kinds of
known criteria of severity and analyzed them by the clinical records of
104 confirmed KHF patients admitted to the Capital Armed Forces
General Hospital, Seoul, Korea between Jan. 1988 and Dec. 1989 and
observed correlations of clinical features classified into 56 items to each
criteria. Each scoring system was highly intercorrelated with each other
(r = 0.66 — 0.88, P < 0.01). Clinical features or laboratory findings
highly correlated (P < 0.01); severity scores were as follows, a.)
Laboratory findings: BUN, serum creatinine, cholesterol, hemoglobin,
hematocrit, platelet counts, SGOT, SGPT, leucocyte counts. b.) Clin-
ical features: duration of anuria or oliguria, diuresis, hypotension and
hypertension; frequency of hemodialysis; degree of hypotension and
hypertension; presence of confusion, irritability, pituitary dysfunction,
epistaxis, melena, gross hematuria; use of narcotic analgesics; admin-
istration of oxygen. Duration of febrile phase, initial titers of antibody
had no significant correlation with any severity score. These data may
help classify the severity of KHF.
Serum LDH and LDH isoenzyme activities in Korean hemorrhagic
fever. W.S. Yang, C.S. Lim, J.S. Han, S. Kim, and J.S. Lee, Seoul
National University College of Medicine, Seoul, Korea. We observed
the changes of serum lactate dehydrogenase (LDH) and LDH isoen-
zyme activities and the correlation with other clinical parameters
according to the phase of KHF were studied in 29 patients who had
typical clinical manifestions and were diagnosed serologically. The
results were as follows; 1.) The serum total LDH activity peaked to
1167.2 109.2 U/liter (mean SE, P < 0.05) at the hypotensive-oliguric
phase, and thereafter decreased to 660.4 58.7 U/liter at the early
diuretic phase, to 486.3 19.2 U/liter at the late diuretic phase, and to
335.2 17.8 U/liter at the convalescent phase. 2.) The changes of the
LDH isoenzyme fractions according to the phase of illness were as
follows; The LDH1 and LDH2 fractions decreased to 17.5 0.9% (P <
0.05) and 24.5 0.9% (P < 0.05), respectively, at the hypotensive-
oliguric phase, and thereafter increased and normalized to 25.1 1.3%
and 32.1 1.1%, respectively, at the late diuretic phase. The LDH3
fraction increased to 26.8 0.5% (P < 0.05) at the early diuretic phase,
and thereafter decreased to 22.9 0.9% at the late diuretic phase. The
LDH4 fraction increased to 19.0 0.9% (P < 0.05) at the hypotensive-
oliguric phase, and thereafter decreased and normalized to 10.4 0.8%
at the late diuretic phase. The LDH5 fraction slightly increased to 13.7
1.0% (P > 0.05) at the hypotensive-oliguric phase, and thereafter
decreased to 8.3 1.5% at the convalescent phase. 3.) The change of
serum LDH activity correlated with that of serum aspartate aminotrans-
ferase (AST) (r = 0.60, P < 0.01), creatinine kinase (CK) (r = 0.77, P
<0.01), platelet count (r = 0.68, P < 0.01), blood urea nitrogen (BUN)(r = 0.69, P < 0.01), and creatinine (r = 0.55, P < 0.01) among the
clinical parameters. The change of serum LDH4 fraction correlated
with that of serum AST (r = 0.76, P < 0.01), CK (r 0.70, P < 0.01),
platelet count (r = 0.55, P < 0.01). 4.) The changes of clinical
parameters which showed correlation with that of serum LDH and
LDH isoenzymes were as follows; The CK increased to 448.0 72.4
U/liter (P < 0.05) at the hypotensive-oliguric phase, and thereafter
decreased to 87.1 13.3 U/liter at the late diuretic phase. The AST
increased to 203.3 35.7 U/liter (P < 0.05) at the hypotensive-oliguric
phase, and thereafter decreased to 47.2 4.4 U/liter at the late diuretic
phase. The platelet count decreased to 52.9 8.5 X 103/mm3 (P < 0.05)
at the hypotensive-oliguric phase, and thereafter increased to 194.8
13.3 x l03/mm3 at the late diuretic phase. The BUN increased to 103.4
4.9 mg/dl (P < 0.05) at the hypotensive-oliguric phase, and thereafter
decreased to 19.3 1.5 mg/dl at the convalescent phase. The serum
creatinine increased to 9.3 0.5 mg/dl (P < 0.05) at the hypotensive-
oliguric phase, and thereafter decreased to 1.5 0.0 mg/dl at the
convalescent phase. In summary, the serum LDH increased signifi-
cantly at the hypotensive-oliguric phase, and all the LDH isoenzyme
fractions increased also, but the change of LDH4 fraction was promi-
nent. The change of serum LDH correlated with that of serum CK,
AST, platelet, BUN, and the serum creatinine.
Change of lymphocyte subsets during Korean hemorrhagic fever
(KHF). Y.G. Kim, J.S. Han, S. Kim, and J.S. Lee, Seoul National
University College of Medicine, Seoul, Korea. Humoral immune re-
sponse to Hantanvirus infection was well known but there have been a
few reports on the cellular response in man. To investigate the cellular
immune response to Hantavirus in man, lymphocytes subsets were
measured in 27 patients with serologically confirmed KHF from 3 to 33
day of illness and compared with those in 29 normal controls (NC). The
subsets were measured by flow cytometry with monoclonal antibodies
to specific cell surface antigens which identify pan T cell (CD3) and
helper (CD4), suppressor (CD8) subsets of lymphocytes. Total lympho-
cytes counts and CD3+ cells in febrile (3613 506 mm3, 2568 569
mm3) and hypotensive (3603 654 mm3, 2363 406 mm3) phase were
greater than NC (1899 363 mm3, 1288 303 mm3) and returned to
normal range in oliguric phase and thereafter. When the helper/
suppressor ratios (CD4/CD8) of all patients were analyzed together,
these ratios were decreased in febrile (0.5 0.17), hypotensive (0.65
0.18), oliguric (0.66 0.10) and diuretic (0.66 0.10) phase as
compared with 1.54 0.10 in NC. In the convalescent phase, it
increased to 1.10 0.10 compared with those in febrile to diuretic phase
but did not return to normal range. When the patients were dichotomi-
tized into two groups according to the severity of illness, CD4/CD8 ratio
in the convalescent phase returned to normal in mild form (1.39 0.20)
but in severe form (0.85 0.11) it remained decreased compared with
those in NC. In conclusion, cellular immune response in KHF may be
associated with clinical severity of illness (values are mean SE).
Ureteral obstruction caused by aortic and iliac artery aneurysm. J.H.
Earm, J.S. Han, S. Kim, S.f. Kim, and J.S. Lee, Departments of
Internal Medicine and General Surgery, Seoul National University
College of Medicine, Seoul, Korea. Aortic or iliac artery aneurysm is
known as the rare cause of ureteral obstruction, and it is the perianeu-
rysmal fibrosis rather than aneurysm itself that causes obstruction. We
experienced 3 cases or ureteral obstruction, 2 of which were caused by
perianeurysmal fibrosis and one by mycotic aneurysm. The first case
was that of 61-year-old male patient who was admitted because of
azotemia. Bilateral ureteral obstruction was detected by kidney and
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urinary tract ultrasonography. Computed tomography and magnetic
resonance imaging confirmed incomplete bilateral ureteral obstruction
resulting from perianeurysmal fibrosis of aorta. The second case was
that of 51-year-old male who were admitted because of right flank pain.
Right ureteral obstruction was detected by kidney and urinary tract
ultrasonography. Renal scintigraphy, aortography and computed to-
mography revealed aortic and iliac artery aneurysm. The surgery was
performed and the cause of obstruction was confirmed as perianeurys-
mal fibrosis. The third case was that of 16-year-old male who had
mycotic aneurysm of left iliac artery as a complication of infective
endocarditis caused by Staphylococcus aureus. The surgery was per-
formed and the cause of obstruction was confirmed as mycotic aneu-
rysm itself. These 3 cases were presented with different chief com-
plaints each other, but diagnosed as ureteral obstruction due to
aneurysm. So if ureteral obstruction of no apparent cause were to be
diagnosed we should consider the possibility of aortic or iliac artery
aneurysms and vice versa.
A case of herpetic esophagitis in renal transplanted patient. K.C. Choi,
Y.H. Park, K.S. Kim, 5G. Choi, J.S. Rew, and Y.J. Kang, Department
ofMedicine, Chonnam University Medical School, Kwangju, Korea.
Viral esophageal infection is common in an immunocompromized host.
Chemotherapy, organ transplantation, malignancy and prolonged ste-
roid therapy are also frequently implicated as predisposing factors. The
first description of herpetic esophagitis was by Pearce in 1943. Herpetic
esophagitis in renal transplanted patient is seen rarely. Diagnosis and
differential diagnosis with other infectious esophagitis is made by
clinical features of dysphagia and odynophagia, esophagoscopy, dou-
ble-contrast esophagogram, brushing cytology and radioimmunoassay
using monoclonal antibodies. We experienced a herpetic esophagitis in
a renal transplanted patient who was treated with methyiprednisolone
pulse therapy due to acute rejection. A 28-year-old woman presented to
us with a history of generalized edema and dyspepnea. She had
hemodialysis after subclavian vein catheterization and had renal trans-
plantation on 40th hospital day. Two weeks after renal transplantation,
she had methyiprednisolone pulse therapy due to acute rejection and
improved clinically. Twenty-five days after the operation, he com-
plained dysphagia, odynophagia and substernal pain. Esophagoscopy
and biopsy were done. The esophagoscopic finding revealed hyperemic
elevated mucosa with central ulceration and yellowish plaque in a
ragged margin, and normal surrounding mucosa. She was treated with
acyclovir and decreased dosage of immune suppressive agent in the
suspicion of herpetic esophagitis. She improved clinically. Afterwards
herpetic esophagitis was confirmed pathologically. Follow-up esopha-
goscopy revealed completely normal mucosa.
Percutaneous transluminal angioplasty for post-renal transplantation
renal artery stenosis in children. N. Heo, S. Lee, C. Ko, and J. Koo,
Department ofPediatrics, School of Medicine, Kyungpook National
University, Taegu, Korea. In the majority of cases, renal transplanta-
tion is the preferred therapy for end-stage renal diseases, and over the
past several years, this modality of therapy has been utilized increas-
ingly in children with ESRD. However, the reported incidence of
post-transplantation renal artery stenosis (RAS) is approximately 20%
in children, compared to 5 to 10% in adults. Surgical correction of RAS
has been done over several years. However, the success rate of this
technique is low in children. An alternative approach is percutaneous
transluminal angioplasty (PTA). We report excellent results of success-
ful dilatation of RAS using PTA in two children with post-transplanta-
tion RAS. Post-transplantation RAS occurred in two of five renal
transplant children (age 10 to 15 years). The first child, a 14-year-old
girl, had recurrent hypertension for 4 months after renal transplantation
and was diagnosed as RAS by selective angiography. Her blood
pressure remained normal for 3 months after PTA and no antihyperten-
sive drugs were used. The other child, 15-year-old boy, had persistent
hypertension after renal transplantation for 1 month, and was diagnosed
as RAS by selective angiography. His post-PTA blood pressure re-
mained normal with the aid of a half dose of antihypertensive drugs. In
conclusion, it can be said that PTA is a safe and effective mode of
therapy for post-transplantation RAS in children.
Estimation of kidney size from the body size in children. K. Kim and
J.H. Park, Department of Pediatrics & Radiology, KonKuk University
College of Medicine, Seoul, Korea. To estimate kidney size from the
body size, we measured kidney lengths and kidney widths in 752 normal
children between 0 and 15 years by ultrasonography. Body weight (BW;
kg), body height (length) (BH; cm), body surface area (SA; m2) and age
(yr) were also measured. Kidney lengths and widths were well corre-
lated with body height or body surface area rather than body weight or
age. The following regression equations were obtained.
r P<
Kidney length (Y) (cm)
1.64 + 0.047X (BH) 0.9569 0.001
3.14 + 4.359X (SA) 0.9380 0.001
3.96 + 0.116X (BW) 0.8903 0.001
4.48 + 0.360X (age) 0.8852 0.001
3.83 + 0.l73X (age l yr; m) 0.8326 0.001
5.52 + 0.234X (age l yr) 0.8849 0.001
Kidney width (cm)
1.05 + 0.022X (BH) 0.9377 0.001
1.73 + 2.055X (SA) 0.9356 0.001
2.10 + 0.056X (BW) 0.9015 0.001
2.36 + 0.067X (age) 0.8693 0.001
2.07 + 0.083X (age l yr; m) 0.8109 0.001
2.83 + 0.111X (age l yr) 0.8254 0.001
Therefore, normal kidney lengths and kidney widths could be estimated
from the factors of body size such as body height, body surface area,
body weight, or age.
